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Abstract 
β-barrel membrane proteins play important structural and functional roles in Gram negative 
bacteria and in mitochondria and chloroplasts of eukaryotes.  A conserved machine is responsible 
for the folding and insertion of β-barrel membrane proteins but its mechanism remains largely 
unknown.  In E. coli, a five protein β-barrel assembly machine (Bam) assembles β-barrel proteins 
into the outer membrane (OM).  Among all β-barrel membrane proteins in E. coli, the β-barrel 
component of the OM LPS translocon is one of only two essential β-barrels, the other being the 
central component of the Bam machinery itself.  The OM LPS translocon, which consists of OM 
β-barrel protein LptD (lipopolysaccharide transport) and OM lipoprotein LptE, is responsible for 
the final export of LPS molecules into the outer leaflet of the OM, resulting in an asymmetric 
bilayer that blocks the entry of toxic molecules such as antibiotics.  This thesis describes the 
characterization of the biogenesis pathway of the OM LPS translocon and its folding and insertion 
into the OM by the Bam machinery.  
An in vivo S35-Methionine pulse-labeling assay was developed to identify intermediates 
along the biogenesis of the OM LPS translocon.  Seven intermediates were identified along the 
pathway. We show that proper assembly of the OM LPS translocon involves an oxidative disulfide 
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bond rearrangement from a nonfunctional intermediate containing non-native disulfides.  We also 
found that the rate determining step of OM LPS translocon biogenesis is β-barrels folding process 
by the Bam machinery.  
Using in vivo chemical crosslinking, we accumulated and trapped a mutant form of LptD 
on BamA, the central component of the Bam machinery.  We extended the S35-Methionine pulse-
labeling method to allow chemical crosslinking of substrates on the Bam complex and trapped 
LptD while it was being folded on the Bam machine.  We demonstrated that the interaction 
between LptD and BamA is independent of LptE, while that between LptD and BamD, the other 
essential component of the Bam complex beside BamA, is LptE dependent.  Based on these 
findings, we proposed a model of Bam-assisted folding of the OM LPS translocon in which LptE 
templates the folding of LptD.  
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1.1.  Introduction 
Gram-negative bacteria have a unique structure.  They are comprised of two aqueous 
compartments enclosed by two different kinds of lipid bilayer membranes.  The cytoplasm, where 
all protein synthesis takes place, is engulfed by the inner membrane (IM). The periplasm, where 
the peptidoglycan layer, known commonly as cell wall, is located, is sandwiched between the IM 
and the outer membrane (OM) which directly contacts extracellular environment (Fig. 1.1).  This 
unique double-membrane structure offers Gram-negative bacteria more protection from their 
surroundings than those Gram-positives which have only a single membrane.  Between the two 
membranes of Gram-negative bacteria, the OM is of special interest, as it contains unique 
structural features that contribute largely to the impermeability against toxic compounds such as 
antibiotics and bile salts (1).  This special feature is the presence of a lipopolosaccharide (LPS) 
layer that composes the outer leaflet of the OM, which makes the OM an asymmetric bilayer with 
the outer leaflet being LPS and inner leaflet being phospholipids (PL) (Fig. 1.1) (1).    
This thesis presents biochemical studies on the folding and assembly pathway of the key 
component in LPS transport, the LPS translocon at the OM of the model Gram-negative organism, 
Escherichia coli.  This work is focused on two main questions that we are trying to answer: 1. 
What is the biogenesis pathway of the LPS OM translocon? 2. How is the LPS OM translocon 
folded into the OM?  
This chapter provides an introduction to OM biogenesis.  Firstly, we take a general look at 
the composition of OM in terms of its lipids and proteins.  Secondly, we will discuss LPS 
biogenesis, with a focus on LPS transport and assembly to its final destination.  Thirdly, we are 
going to provide an overview of how proteins at the OM are assembled, with an emphasis on β-
barrel protein biogenesis.   
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1.1.1.  Outer membrane of Gram-negative bacteria is an asymmetric bilayer 
Biological membranes not only define cellular compartments but also determine the 
permeability of those compartments.  They control the traffic in and out of the compartments to 
obtain optimal cell growth and regulation.  In Gram-negative bacteria, the OM mainly serves as a 
selective permeability barrier that limits entry to the cell to a small and very well defined group of 
molecules (1).   
Typical phospholipid bilayer membranes, such as the IM of Gram-negative bacteria, form 
a tight barrier to hydrophilic molecules, but due to their largely hydrophobic nature, they are not 
very effective in blocking the entry of hydrophobic molecules from entering the cell.  What is 
unique about the OM of Gram-negative bacteria is that it is very effective in preventing both 
hydrophobic and hydrophilic molecules from cell entry yet at the same time allowing the uptake 
of necessary compounds such as nutrients (1).  The OM of Gram-negative bacteria must have some 
very special structural features to achieve this highly sophisticated functional goal (Fig. 1.1 and 
1.2).   
The OM of Gram-negative bacteria is special both on a protein level and a lipid level.  On 
a protein level, which we will discuss in detail later, it contains two different kinds of proteins (Fig. 
1.1): membrane β-barrel proteins (2) and membrane lipoproteins (3).  Outer membrane β-barrel 
proteins (OMPs) are integral membrane proteins that adopt a barrel-like structure in which β-sheets 
are wrapped around to form a cylinder shape with hydrogen bond (H-bond) interaction between 
each single β-strand including the first and last one (2, 4).  OMPs have very stable secondary 
structures that are not easily perturbed since there are no unsatisfied H-bond interaction between 
β-strands, (2, 4).  Moreover, as OMPs form a cylindrical shape at the OM, they provide hydrophilic 
channels that connect the periplasm with extracellular environment.  Such channels provide 
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passage to small hydrophilic molecules (< 600 Da), allowing them to passively-diffuse into the 
cell (1).  OMPs are also involved in many other important cellular functions, such as active 
transport of specific nutrients (5), export of toxic small molecules (6), protein secretion (7), and 
the assembly of the OM(8).  Membrane lipoproteins at the OM tether to the inner leaftlet of the 
OM via a lipid anchor (9).  A large fraction of the total lipoprotein population attach to the cell 
wall either by covalent bond (10) or non-covalent interaction (11), presumably providing support 
for the cell envelope.   
 
Figure 1.1.  (Taken directly from ref. 12 with caption).  Structure of the gram-negative cell 
envelope.  In Gram-negative bacteria, the cytoplasm is surrounded by the inner membrane (IM), 
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that is, a phospholipid (PL) bilayer that also contains proteins. There are two types of proteins in 
the IM: integral IM proteins, which span the membrane through α-helical transmembrane domains, 
and IM lipoproteins, which are anchored to the outer leaflet through a lipid moiety. The periplasm 
is the aqueous compartment bounded by the IM and the outer membrane (OM); it contains soluble 
proteins and the peptidoglycan layer. The OM is anchored to the rest of the cell via proteins that 
are covalently attached to the peptidoglycan. The OM is asymmetric, as it contains phospholipids 
in the inner leaflet and lipopolysaccharide (LPS) in the outer leaflet. In addition, the OM contains 
two types of proteins, integral OM proteins (OMPs) and lipoproteins. 
 
 
Figure 1.2.  (Taken directly from ref. 12 with caption).  Electron micrograph (EM) of Veillonella 
illustrating the ultrastructure of the Gram-negative cell envelope. Bladen and Mergenhagen 
published this micrograph in 1964 (ref. 13) and they labelled the different structures as the outer 
membrane (OM), the solid membrane (SM), which is known nowadays as the peptidoglycan, and 
the plasma membrane (PM), which we refer to as the inner or cytoplasmic membrane. Figure is 
reproduced, with permission, from ref. 13 © (1964) American society for Microbiology. 
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On a lipid level, the OM of Gram-negative bacteria is a lipid bilayer with asymmetric lipid 
composition, the inner leaflet being phospholipids and the outer leaflet LPS, a large amphiphilic 
molecule that is essential for viability in most Gram-negative bacteria (Fig. 1.3) (1, 12-17).  This 
remarkable discovery was made decades ago through a series of EM and biochemical labeling 
experiments which taken together conclude that LPS is only found on the outer leaflet of the OM 
(15-17).   
 
Figure 1.3.  (Taken directly from ref. 12 with caption).  Structure of Escherichia coli LPS.  The 
structure of E. coli LPS with a K-12 core region is shown. The structure of LPS among different 
species is very diverse (18) and bacteria can further modify the typical LPS structure in response 
to environmental signals and defects in envelope conditions (19-22). EtN, ethanolamine; Gal, d-
galactose; Glu, d-glucose; Hep, l-glycerod- manno-heptose; KDO, 3-deoxy-d-manno-oct-2-
ulosonic acid; P phosphate.  
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LPS molecules are polyanionic due to the phosphate groups on the polar heads.  At the OM, 
those anionic moieties form ionic interactions with divalent cations such as Mg2+, resulting in a 
tight mesh with very limited lateral diffusion efficiency (1).  Such structural features of the LPS 
layer give rise to the impermeability of the OM, protecting Gram-negative bacteria from harsh 
growth conditions (1).   
 
1.1.2.  Lipopolysaccharide biogenesis  
1.1.2.1.  Lipopolysaccharide biosynthesis in the cytoplasm 
The biosynthesis pathway of LPS has been extensively studied in the past, partly because 
of its role in triggering strong immune response (14).  The hydrophobic core of LPS, called Lipid 
A (Fig. 1.3), can activate Toll-like receptor 4 (TLR4), which leads to an over-production of 
inflammation-related proteins cascades and triggers septic shock (23).  Studies on the biosynthetic 
pathway of LPS provides opportunities to use small molecules that inhibit the function of key 
enzymes which eventually could shut down the production of LPS (24, 25).  Some of the inhibitors 
are already in clinical trials.   
In E. coli, LPS is composed of two parts: a hydrophobic hexa-acylated glucosamine 
disaccharide anchor and a hydrophilic core oligosaccharide group plus O-antigen polysaccharides 
(Figure 1.3) (14).  LPS synthesis starts in the cytoplasm with the assembly of Kdo2-lipid A, which 
has been extensively characterized and reconstituted by Raetz and co-workers (14).  This pathway 
consists of nine steps that converts starting material UDP-N-acetylglucosamine (UDP-GlcNAc) to 
Kdo2-lipid A (Fig. 1.4), which is then decorated by subsequent addition of the inner and outer core 
sugars (14).   
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Figure 1.4.  Biosynthesis of Kdo2-lipid A (taken directly from Dr. Shu Sin Chng’s dissertation).   
 
1.1.2.2.  Lipopolysaccharide translocation across the inner membrane 
LPS precursor molecules need to be flipped from the inner leaflet of the IM to the outer 
leaflet of the IM before sugar modifications and subsequent transport to the OM can take place (1).  
This flipping process requires energy as the barrier for a polar “head group” to pass the non-polar 
lipidic membrane is high.  The polar head groups will undergo a de-solvation and re-solvation 
process during the flip, in which the water molecules that surround the polar head groups need to 
first dissociate before those head groups can pass the membrane and subsequently re-solvate in the 
periplasm with water molecules there.   
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The protein that powers the translocation of LPS across the IM is MsbA, which is an 
essential IM integral protein that forms an ABC transporter that utilizes ATP as the energy source 
(26-28).  MsbA was initially identified as a suppressor for a mutant that produced defective LPS 
(26).  It was later shown that wild-type LPS stimulates ATP hydrolysis by MsbA better than the 
defective LPS, suggesting that MsbA may be directly involved in LPS transport (27).  Finally, 
Doerrler and coworkers used location specific LPS modification enzymes to show that MsbA is in 
fact an LPS flippase that moves LPS from the inner leaflet of IM to the outer leaflet of IM (28). In 
their experiment, they found that the modification of newly synthesized LPS by two enzymes that 
only tailor LPS molecules at the outer leaflet of the IM is MsbA dependent, however, modification 
of newly synthesized LPS by a different enzyme that functions at the inner leaflet of the IM is not 
(28).   
 
Figure 1.5.  Three conformations of homodimeric MsbA (taken directly from ref. 90).  One 
monomer in each model is colored with a rainbow gradient (N-terminus is blue, C terminus is red), 
and the other is white.  AMP-PNP molecules are displayed as blue sticks in the nucleotide-bound 
structure. 
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MsbA orthologs have been crystalized in different conformations, and a model of how 
MsbA flips LPS molecules was proposed based on those structures (29).  Three different 
conformations (Fig. 1.5) of MsbA from three closely related bacteria were shown: an inward 
opening conformation of apo-MsbA from E. coli; an inward closed conformation of apo-MsbA 
from Vibrio cholerae; and finally a conformation of MsbA from S. typhimurium that is outward-
facing and bound to a nucleotide analog, ATP-PNP (29).  These different conformations imply 
that MsbA may undergo a substantial conformational change when catalyzing the LPS 
translocation reaction powered by ATP-hydrolysis.  LPS is likely to bind to the inward opening 
conformation, which may trigger a conformational change that transits the protein to an inward 
closed conformation (29). Translocation of LPS could then take place when MsbA shifts to the 
outward-facing conformation, possibly induced by ATP binding.  Subsequently, ATP hydrolysis 
completes the catalytic cycle and resets MsbA to the original inward opening conformation.   
 
1.1.2.3.  Lipopolysaccharide transport from the IM to the OM 
How LPS molecules are transported from the IM to their final destination at the outer leaflet 
of the OM is less well known.  It is a challenging problem for the cell to pull out such large, 
amphiphilic molecules from the IM, transport them through the aqueous periplasm and finally 
release them across the OM.  Seven essential proteins that form a trans-envelop Lpt 
(lipopolysaccharide transport) machinery have been identified in recent years, which is proposed 
to transport LPS from IM to its final destination (12, 30).  Four of these Lpt proteins, LptBCFG, 
form a complex that partly consists of an ABC transporter that utilizes ATP hydrolysis energy to 
initiate LPS movement from the IM (31-38).  This complex has been purified and performs ATPase 
activity (34). Two OM proteins, LptD and LptE, which are OM integral β-barrel protein and OM 
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lipoprotein, respectively, form a tight plug-and-barrel complex that mediates the final insertion of 
LPS into the outer leaflet of the OM (39-44).  A periplasmic protein LptA mediates the interaction 
between the IM and OM Lpt proteins, allowing the formation of a protein-based bridge that serves 
as the passage of LPS molecules across the periplasm (45-49).   
 
1.1.2.3.1.  Identification of Lpt proteins 
LptD was originally implicated to relate to OM permeability about twenty five years ago 
(50).  It was first found in a mutant allele, imp4213 (now referred to as lptD4213), that suppresses 
the lethal lamB- deletion when maltodextrins is the only nutrient available. This mutation 
presumably makes cells more permeable so maltodextrins could diffuse into the cell in the absence 
of importer LamB (50).  The lptD4213 mutant rescues the lethality of lamB- allele when growing 
in medium in which maltodextrins is the only carbon source (50).  However, since lptD4213 has a 
much more permeable OM, it is very susceptible to small molecules such as antibiotics and 
detergents that wild type cells are normally resistant to (50).  LptD is a highly conserved (39) 
essential integral β-barrel protein, with a small N-terminal periplasmic domain and a large C-
terminal β-barrel domain (42).  LptD contains four cysteine residues, two of which reside in the 
N-terminal periplasmic domain and the other two in the C-terminal β-barrel domain; three out of 
the four cysteine residues are well conserved across species (39, 43).  Mobility of LptD on SDS-
PAGE is different when samples are pre-treated with or without β-mercaptoethanol (β-ME), a thiol 
reducing agent, suggesting that the cysteine residues in LptD form intramolecular disulfide bonds 
(1, 39, 43).  Depletion of LptD in E. coli produces abnormal OM; when LptD is depleted newly 
synthesized LPS molecules accumulate in the IM, which implies that LptD may be involved in 
LPS transport (39, 41).   
12 
 
In most Gram-negative bacteria, LPS is essential for cell viability.  Thus it is not possible 
to delete LptD and observe phenotypes related to LptD deletion if LptD is in fact related to LPS 
biogenesis.  However, in Neisseria meningitidis, LPS is not essential (51, 52), which makes it 
possible to delete the lptD gene.  In a mutant where the lptD gene is disrupted, LPS molecules 
produced could not be modified by tailoring enzymes at the OM or in the extracellular environment, 
suggesting that LPS transport is impaired in this mutant (51).  These results implicated that LptD 
is involved in the transport of LPS.  In E. coli, LptD was later shown to co-purify with an essential 
OM lipoprotein LptE (41).  Similar to LptD, depleting LptE also results in mislocalization of 
newly-synthesized LPS, as they would accumulate in the IM instead (41).  LptD and LptE could 
be purified as a stable complex in vitro, in which the lipoprotein is protected from protease 
degradation, suggesting that a large part of LptE sits in the lumen of the β-barrel of LptD (42).  
Further evidence to support this plug-and-barrel structure was obtained by introducing photo-
activatable amino acids into randomly chosen positions of LptE and detecting positions that 
physically contact LptD (44).  Five positions around LptE were found that interact with LptD, 
among which one of the positions interacts with a putative extracellular loop of LptD, suggesting 
that LptE sits inside of LptD (44).   
Random transposon mutagenesis in E. coli leads to the discovery of another three essential 
genes involved in LPS biogenesis.  When transposon-insertion disrupted lptA, lptB and lptC , cells 
become dead (53, 54).  Furthermore, similar to that of LptD and LptE, depletion of LptA, LptB or 
LptC prevents newly-synthesized LPS from translocating to the OM, suggesting that all three 
proteins are involved in LPS biogenesis (31, 32).  Additionally, WaaL, an LPS modifying enzyme 
that attaches the O-antigen to LPS molecules at the outer leaftlet of the IM, has been shown to 
modify the accumulated LPS molecules at the IM (32, 55).   
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lptF and lptG, two IM transmembrane proteins that are part of an ABC transporter system 
with LptB, were identified by bioinformatics (33). This approach took advantage of the fact that 
LPS is one of the defining character of Gram-negative bacteria, thus genes involved in LPS 
biogenesis should be found in all Gram-negative bacteria, including those endosymbionts that have 
extremely small genomes. By comparing the genome of the bacterial endosymbiont Blochmannia 
floridanus with that of E. coli, two more essential genes with previously unassigned function were 
found.  These two genes were lptF and lptG.  Depletion studies on these two genes produced 
similar results to that of other Lpt protein depletions.  Furthermore, depletion of LptF and LptG 
prevents PagP modification of newly-synthesized LPS, suggesting that both proteins are required 
for LPS translocation to the OM (33). 
 
1.1.2.3.2.  LPS transport across the periplasm via OstA-bridge 
Historically, there were two different models proposed on how LPS molecules travel across the 
aqueous periplasmic space (8, 12, 30).  One model proposes that, similar to the Lol system that 
transport OM lipoproteins (discussed below in Section. 1.1.3.), LPS molecules are transported by 
a periplasmic LPS chaperone, likely LptA, that receives LPS from the inner membrane LptBCFG 
complex and delivers to the outer membrane LptDE complex.  In a different model, the Lpt 
complex forms a seven-protein trans-envelop machinery that spans two membranes, in which LPS 
molecules travels in a continuous fashion from the IM to the OM.  There were reports back in the 
late 1960s that suggested the existence of junctions that connect the two membranes from EM 
snapshots (56, 57).  Those proposed junctions, commonly known as “Bayer junctions”, were 
suggested as passages for protein and lipid trafficking between the two membranes.  Although the 
existence of “Bayer junctions” and their relation to protein and lipid transport are very much 
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controversial, it has been reported that newly synthesized LPS molecules were observed near those 
putative “Bayer junctions” (58).   Furthermore, LPS accumulates, although transiently, in an OM 
fraction that is lighter than regular OM (59).  This fraction, OML, in which all seven Lpt proteins 
can be found, contains IM, cell wall, and OM (49, 59).  Additionally, LPS transport to the OM still 
takes place in spheroplasts, where presumably everything that does not attach to the IM is no longer 
present (60).  In those spheroplasts, PagP is still capable of  modifying freshly made LPS molecules, 
suggesting that the LPS transport machinery must remain functional (together with some part of 
the OM) even if the vast majority of periplasm and OM are gone.  These results all favor the bridge 
model of LPS transport.   
Some recent evidence suggested that LPS molecules do take advantage of a protein-based 
bridge that is formed by Lpt proteins to move across the periplasm (38, 48-49, 61-62).  LptD/E, 
the OM components of the Lpt proteins and LptA, the periplasmic Lpt protein, all co-purify with 
his-tagged LptB, LptC or LptF in an affinity pull down, suggesting that they form a physically 
attached complex (49).  The X-ray crystal structures of LptA and the periplasmic domain of LptC 
look very similar to each other; they both adopt β-jellyroll structure, in which hydrophobic amino 
acids sitting inside the jellyroll create a lipid-friendly patch, suggesting a possible passage of LPS 
molecules (Fig. 1.6, 49, 61).  Furthermore, in the structure of LptA, multiple β-jellyrolls connect 
head-to-tail, creating an extended hydrophobic groove along the structure (Fig. 1.6, 49).  
Intriguingly, the periplasmic domain of LptC, LptA and the N-terminal periplasmic domain of 
LptD all belong to the same OstA superfamily, suggesting that similarly structured OstA domains 
could form a protein bridge where LPS molecules can travel along the hydrophobic groove (49, 
61-62).  
15 
 
 
Figure 1.6.  (Taken directly from ref. 49 and 61).  The structure of LptC and LptA.  (A) The 
structure of LptC.  (B) The structure of LptA.  Multipule copies of LptA attach to each other in a 
head-to-tail fashion, creating this fibril structure in which a hydrophobic groove (shown in the 
figure in a space-filling model) can be found.   
 
In vivo biochemical experiments further support this bridge model (38, 48).  LptC, LptA 
and LptD with photo-activatable amino acids incorporated show site-specific interaction between 
LptC-LptA, LptA-LptA and LptA-LptD (48).  These interactions take place at the edge of the β-
jellyrolls, suggesting that similar to what the crystal structure indicated, the β-jellyrolls indeed 
interact in a head-to-tail fashion in the cell.  LptA-LptA interaction indicates that the bridge may 
contain more than one LptA molecule.  Interestingly, specific positions that engage in LptA-LptA 
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interaction were also found to interact with LptD, suggesting that components of the OstA bridge 
connect in a very similar fashion (48).  Furthermore, using the same photo-activatable amino acid 
incorporation technique, LPS has been successfully accumulated on LptC and subsequently 
released to LptA, providing a molecular picture of LPS movement from LptC to LptA (38).  This 
movement is dependent on the presence of the ABC transporter LptBFG and ATP as an energy 
source, indicating that the LPS movement from the IM to the OM is powered by ATP hydrolysis 
(Fig. 1.7, 38).   
 
Figure 1.7.  (Taken directly from ref. 38) Model of LPS transport across the periplasm.  The ABC 
transporter LptBFG complex utilizes ATP hydrolysis energy to release LPS molecules from the 
IM, deliver it them to LptC, where they would be continuously pushed to LptA and LptD.   
 
1.1.2.4.  LPS insertion at the OM 
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LptD and LptE form a tight plug-and-barrel structure at the OM that is responsible for 
receiving LPS molecules that have traveled across the periplasm and eventually putting them into 
the outer leaflet of OM (42-44, 48).  How the LptD/E complex inserts LPS molecules into the outer 
leaflet of the OM is largely unknown.   
Recently, it was shown that intramolecular disulfide bonds in LptD are crucial for its 
activity (1, 43, 48).  Wild type LptD contains four cysteines, two of them in the N-terminal 
periplasmic domain (Cys31 and Cys173) and the other two in the C-terminal β-barrel domain (Cys724 
and Cys725) (43).  In a mature LptD, there are two non-consecutive disulfide bonds that connect 
the two domains, formed between Cys31 and Cys724 ([1,3]), and Cys173 and Cys725 ([2,4]), resulting 
in an oxidized [1,3][2,4]-LptD.  Either one of the two disulfide bonds are sufficient for cell growth, 
however, disulfide bonds that connect the two domains but are not [1,3] or [2,4], such as [1,4] or 
[2,3], do not support growth, suggesting that not all inter-domain disulfide bonds result in a 
functional LptD (43).   
Disulfide bond configuration in LptD also plays an important role in the formation of the 
seven-protein trans-envelop Lpt machinery (48).  Among a set of LptD cysteine mutants that 
includes LptDCCSS, LptDSSCC, LptDSCSC and LptDSCCS, only the functional mutant LptDSCSC is able 
to interact with the periplasmic protein LptA, as judged by photo-activatable crosslinking (48).  
This suggests that only functional LptD is allowed to form the OstA-bridge that spans the two 
membranes with the rest of Lpt proteins (Fig. 1.8), possibly to prevent the formation of non-
functional Lpt machinery that may misplace LPS into undesired places such as the periplasm or 
the inner leaflet of the OM.   
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Figure 1.8.  (Taken directly from ref. 48).  Ordered assembly of the Lpt machinery.  Formation of 
the seven-protein trans-envelop Lpt machine is dependent on correct disulfide bond configuration 
in LptD.  The presence of native disulfide bonds allows the N-terminal periplasmic domain of 
LptD to interact with LptA.   
 
1.1.3.  Biogenesis of OM lipoprotein 
Lipoprotein biogenesis in E. coli has been extensively studied (63, 64).  Like all other 
periplasmic and OM proteins, the synthesis of OM lipoproteins takes place in the cytoplasm as a 
precursor with an N-terminal signal peptide.  The signal pepide acts as a sorting signal that targets 
these proteins to the secretion channel that consists of a protein complex SecYEG, where they are 
secreted across the IM (65).  Once they cross the IM, those pre-lipoproteins undergo a series of 
tailoring modifications that eventually produce mature lipoproteins.  Firstly, the sulfur atom from 
the first cysteine (after the signal sequence) receives a diacylglyceryl group from a 
phosphatidylglycerol (PG) followed by cleavage of the signal peptide occurs at the modifided 
Cysteine residue.   Then the new N-terminal amino acid (the aforementioned cysteine) is acylated, 
19 
 
resulting in a mature lipoprotein that anchors to the membrane by three acyl chains at the very N-
terminus (66).   
 Over the past two decades, Tokuda and co-workers have demonstrated that the Lol 
(localization of lipoprotein) machinery, which consists of five essential proteins (LolABCDE) 
chaperones OM lipoproteins from the IM to the OM (Fig 1.9, 63, 64).  This process takes place in 
three steps: the extraction of OM lipoproteins from the IM, the transport of those proteins across 
the aqueous periplasm and the final insertion of them into the inner leaflet of the OM.  The first 
step is performed by an ABC transporter made of three proteins at the IM, LolCDE.  It has been 
shown that LolCDE recognizes OM lipoproteins in the IM and extracts them from the IM by ATP 
hydrolysis (67-69).  OM lipoproteins are then transferred to LolA, a periplasmic protein that 
chaperones OM lipoprotein across the periplasm (70).  The sorting of the lipoproteins is achieved 
by LolCDE as those lipoproteins that are bound to stay in the IM would not be released by the 
ABC transporter due to a characteristic aspartate residue right after the first cysteine (71).   
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Figure 1.9.  (Taken directly from ref. 63).  A model of OM lipoprotein trafficking.  OM destined 
lipoproteins are released from the IM by LolCDE complex, chaperoned to the OM by LolA, 
received and subsequently inserted into the OM by LolB.   
 
Periplasmic chaperone LolA interacts with the lipid anchor of OM lipoproteins and keeps 
them from aggregation in the aqueous compartment.  LolA then delivers its lipoprotein cargo to 
LolB, an OM lipoprotein itself (Fig. 1.9, 70).  It is still not clear how LolB releases the OM 
lipoprotein into the inner leaflet of the OM.  Structurally, LolB is highly homologous to LolA, 
both having a large hydrophobic pocket that is thought to host the lipoprotein cargo by interacting 
with the lipid anchor (72).  Cargo transfer between LolA and LolB is believed to occur in a “mouth-
to-mouth” fashion in which the two hydrophobic cavities align towards each other and the lipid 
anchor “slides through” from LolA to LolB, as suggested by surveying the LolA-LolB interaction 
surface via incorporation of photo-activatable amino acids (73).  LolB has stronger affinity to OM 
lipoproteins than LolA, which thermodynamically drives the lipoproteins to the OM (74).   
 
1.1.4.  Outer membrane β-barrel protein assembly  
1.1.4.1.  Overview of membrane integral protein assembly 
There are two different kinds of integral membrane proteins in living organisms, α-helical 
and β-barrel, which describe the structure of their characteristic membrane spanning domain (4).  
α-helical membrane proteins have helical bundles that leave hydrophobic amino acids on the 
outside of the bundles, engaging in hydrophobic interaction with membrane lipids.  β-barrel 
membrane protein, on the contrary, spans the membrane by wrapping an extended β-sheet into a 
barrel shape.  These β-barrels have hydrophobic amino acids facing outward to the lipids and 
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hydrophilic amino acids facing inward, forming a channel that allows the passage of small 
hydrophilic molecules to passively diffuse across the membrane.   
Membrane insertion of α-helical integral membrane proteins has been extensively studied 
(Fig. 1. 10, 75, 76).  The Sec machinery folds and inserts each α-helical segment into the membrane 
by releasing the newly formed α-helix via a lateral gate in the machine (77, 78).  This mechanism 
ensures that those individual helices are inserted into the membrane without exposing their 
hydrophobic residues to an aqueous environment.   
Folding and assembly of membrane β-barrel proteins are less well understood.  These 
proteins are found in the OM of Gram-negative bacteria and the outer membrane of mitochondria 
and chloroplasts. Machineries that responsible for their folding and assembly are conserved from 
bacteria to man, therefore, we focus on the assembly pathway in E. coli as a model of β-barrel 
protein assembly.  Similar to OM lipoproteins, OM β-barrel proteins also cross the IM via the Sec 
channel, followed by the cleavage of signal peptide by signal peptidase.  In the periplasm, they 
will interact with chaperones like SurA, Skp and DegP, which prevent OM β-barrel proteins from 
aggregation and keep them in a folding-competent state (4, 79-84).  These chaperones are believed 
to deliver the unfolded OMPs to the β-barrel assembly machine at the OM where they are folded 
and inserted into the membrane (Fig. 1. 10).   
Folding and assembly of OM β-barrel proteins face many challenges that are not seen at 
the assembly of IM α-helical proteins.  Unlike α-helical proteins, in which each individual α-helix 
segments are relatively stable in a lipid membrane thus can be inserted into the membrane one-by-
one, individual β-sheets are highly unstable in a hydrophobic environment as they would have 
unsatisfied H-bonds at the edges of the β-sheets.  These H-bonds are only satisfied once the entire 
β-barrel structure is formed, thus the folding and membrane insertion of β-barrel proteins must be 
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a coupled step at the membrane.  Additionally, unlike the assembly of IM integral proteins, which 
can utilize energy source like ATP, OMP assembly takes place at the OM where no apparent 
energy source is readily available.   
 
Figure 1. 10.  (Taken directly from ref. 4 with caption) Cell envelope protein biogenesis. All 
proteins destined for the periplasm and two membranes are ribosomally synthesized in the 
cytoplasm. Inner membrane (IM) proteins (IMPs) are cotranslationally directed to Sec and inserted 
into the membrane, whereas periplasmic and outer membrane proteins (OMPs) are 
posttranslationally translocated. Soluble periplasmic proteins then fold in this second aqueous 
compartment. Outer membrane (OM) lipoproteins are lipidated at the outer leaflet of the IM and 
then transported to the OM by the Lol pathway. β-barrel OMPs transit the periplasm in unfolded 
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states with the help of chaperones and are then folded and inserted into the OM by the five-protein 
Bam complex.  
 
1.1.4.2.  Identification of the β-barrel assembly machine at the OM 
Components of the machinery that assembles β-barrel proteins were identified through a 
series of discoveries.  BamA, the central component of the Bam complex, was first identified by 
comparing sequence homology of Neisseria meningitidis and chloroplasts and found to be 
involved in OMP assembly (85, 86).   
Other Bam proteins are not that conserved among species so they could not be identified 
by similar methods.  BamB was identified by looking at specific suppressors that rescue OM 
permeability defects caused by a mutation in LptD (lptD4213) (87, 88).  A bamB null mutation 
suppressed some OM defects in lptD4213 by not allowing certain antibiotics from getting into the 
periplasm.  Affinity purification using a his-tagged BamB revealed that BamB is in a complex 
with BamA and three other OM lipoproteins, BamC, D and E (87, 90).  Bam proteins form a stable 
complex both in vivo and in vitro.  The entire Bam complex can be pull down by any of the 
individual components.  Stable sub-complexes with different Bam protein compositions can be 
over-expressed and purified (91).   
 
1.1.4.3.  Structure of Bam proteins 
X-ray crystal structures of individual Bam components have been obtained very recently, 
although little is known with regard to how they interact with each other.  The only complex that 
has been solved is BamCD.   
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BamA, the central component and the most well conserved protein of the Bam complex, 
has two domains: a soluble periplasmic domain and a membrane integrating β-barrel domain.  In 
E. coli, the soluble periplasmic domain is consist of five POTRA (polypeptide transport associated) 
domains which are believed to interact with substrates and chaperones.  The first piece of X-ray 
crystallographic structural information of the Bam components was on the POTRA domains of 
BamA from E. coli (92).  Each POTRA domain consists of two α-helices and three β-strands.  The 
five POTRA domains are the docking sites of Bam lipoproteins, as deleting the POTRA domains 
would result in dissociation of Bam lipoproteins (92). Deleting POTRA 5 (P5) disrupts the 
interaction between BamA and BamCDE, while deleting any of the P2-5 would cause BamB to 
dissociate.  Based on the crystal structure, it is proposed that POTRA domains may engage OMP 
substrates via “β-strand augmentation”, in which the edges of the unfolded OMP’s β-strands 
interact with POTRA domains by forming H-bonds with the β-strands in those domains (92).   
Very recently, X-ray crystallographic structures of BamA from N. gonorrhoeae and H. 
ducreyi have been obtained (Fig. 1. 11, 93).  The POTRA domains of BamA adopt two different 
conformations in relation to the β-barrel in those structures (Fig. 1. 11A-C).  The POTRA domain 
(P4 and P5, as P1-3 is deleted in this structure) of BamA from H. ducreyi (HdBamAΔ3) turns 
away from the β-barrel, leaving the barrel in an “open” state, while the POTRA from N. 
gonorrhoeae (NgBamA) interacts with periplasmic loops of BamA, resulting in a “closed” 
conformation in which the periplasmic opening of the β-barrel is blocked by the P5 domain.  The 
difference in the conformation of POTRA domains may imply a gating mechanism by which 
access of the β-barrel is regulated by the POTRA domain.   
Another interesting structural feature arising from the two BamA structures is the 
conformation of the last β-strand in relation to the first (Fig. 1. 11D, 93).  In HdBamAΔ3, β strand 
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1 and 16 form multiple H-bonds, closing the barrel as expected, however, in NgBamA, β strand 1 
and 16 are connected by only two H-bonds, while a large part of β strand 16 is tucked inside the 
lumen of the barrel (Fig. 1. 11D, 93).  This part of a destabilized barrel could potentially provide 
a lateral gate like that in the Sec machinery which allows substrates to enter the lipid membrane, 
however, it is not clear at all whether this destabilized β strand interaction is physiologically 
relevant to the function of BamA.   
It is note-worthy from the structure of BamA that the hydrophobic belt from the β-barrel is 
greatly reduced on the side of the β1-β16 compared to the other side (93).  On the β1-β16 side of 
the barrel, the hydrophobic belt is about 9Å thick, while on the opposite side, it is about 20Å.  This 
seems to suggest that the thickness of the lipid membrane is asymmetric around BamA.  The side 
of β1-β16 has a much thinner hydrophobic membrane than the opposite side, implying that BamA 
may distort the topology of membrane around it.  Whether the BamA induced membrane distortion 
facilitates OMP assembly is not known.   
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Figure 1.11.  (Taken directly from ref. 93 with caption) Structure of BamA from N. gonorrhoeae 
and H. ducreyi.  (A) The HdBamAΔ3 crystal structure in cartoon representation showing the β-
barrel (green) and POTRA domains 4 and 5 (purple and blue, respectively).  (B) The NgBamA 
crystal structure showing the β-barrel (gold) and POTRA domains 1–5 (cyan, red, green, purple 
and blue, respectively).  (C) Alignment of HdBamAΔ3 (green) and NgBamA (gold) showing open 
and closed conformations for the POTRA domains, which may serve as a gating mechanism for 
regulating substrate access to the inside of the b-barrel.  (D) Compared to HdBamAΔ3 (green), β-
strand 16 is disordered and tucked inside the b-barrel of NgBamA (gold). Arrowheads indicate the 
location of the C-terminal strand in HdBamA (black) and NgBamA (red). 
 
X-ray crystal structures of BamB, C, D, E were also obtained in recent years (94-100).  
However, how they function with BamA is still largely unknown.     
 
1.1.4.4.  Mechanistic studies of the Bam complex 
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How the Bam complex folds β-barrel proteins is still largely unknown.  There are many 
challenges in trying to obtain a step-by-step mechanistic picture of β-barrel folding at the Bam 
machinery.  It is difficult to observe intermediates during folding on the Bam complex as this is 
generally a highly efficient process, which means that half-finished products are extremely 
difficult to detect.  We are going to discuss more about identifying and characterizing folding 
intermediate on the Bam complex in Chapter Three.   
The Bam complex must recognize its substrates from the periplasm.  It is believed that 
periplasmic chaperones, such as SurA, Skp, DegP and FkpA are responsible for maintaining 
unfolded β-barrel substrates in a folding competent state and delivering them to the Bam complex.  
SurA, the major chaperone in the periplasm, has been shown to chemically crosslink to BamA, 
suggesting that it directly interacts with BamA (82, 101, 102).  Recently it has been shown that 
SurA interacts with P1 domain of BamA, which is consistent with its hypothesized role in 
delivering substrates to the periplasmic part of Bam complex (101, 102).   
The process of Bam-assisted β-barrel assembly has recently been reconstituted from 
purified components in proteoliposomes (91, 103, 104).  OmpT, an outer membrane protease was 
first used as a substrate for in vitro Bam-assisted β-barrel assembly in proteoliposome as it is 
convenient to take advantage of its protease activity as a reporter for β-barrel assembly (91).  It 
was found that, when unfolded OmpT was pre-incubated with SurA and mixed with purified 
BamABCDE complex in a proteoliposome, the amount of folded OmpT increases with time (91).  
This process takes place without ATP or other energy source, which is consistent with the 
environment at the OM.  It has also been demonstrated that the Bam complex was able to carry on 
multiple turnovers of the folding reaction, showing that this reconstituted folding process is also 
catalytic (103).  
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The assembly of BamA by the Bam complex has also been studied in proteoliposomes 
(104).  In E. coli, there are only two essential β-barrel proteins at the OM, BamA and LptD; 
arguably, they are the most important substrates of the Bam complex.  Interestingly, 
subcomponents of the Bam complex, some of which even without BamA, the central component, 
are able to assemble BamA into a membrane (104).  Even a single lipoprotein, such as BamB, C, 
or D alone, are able to fold BamA, although less effectively than a complete Bam complex.  
Additionally, chaperones are not needed in BamA assembly as Bam complex is capable of 
inserting BamA into a membrane in the absence of SurA or any chaperone.  These results indicate 
that BamA is a very special substrate of the Bam complex.  We are going to characterize Bam 
assisted folding of LptD in Chaper Three.   
 
1.2.  Perspectives 
In the past decade, the majority of, if not all, players in the LPS transport and OMP 
assembly pathways have been identified.  Major achievements have been made in understanding 
how they function in the cell in the past few years during my PhD.  Five years ago when I started 
my PhD, it was not at all clear how the Lpt machinery is assembled or how the Bam complex folds 
its substrates; as of now, we have yet to provide a complete answer to those questions but we have 
made significant progress towards answering them.  Actually, structural and biochemical tools 
developed in recent years make us more powerful than ever in understanding how the OM is 
assembled.   
This thesis describes the progress in trying to understand two central questions in OM 
biogenesis: 1. how does the biogenesis of the OM LPS translocon, the LptD/E complex take place 
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and, 2. how is the OM LPS translocon assembled by the Bam complex.  We have extensively 
characterized the biogenesis pathway of the OM LPS translocon by identifying seven 
intermediates along the pathway, and further shown a different form of the Bam complex that is 
required in assembling the OM LPS translocon by characterizing folding intermediates on the Bam 
complex.  These understandings may in the future allow the development of antibiotics that target 
these pathways to cure Gram-negative bacterial infections.    
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Characterization of the Biogenesis Pathway of the Outer Membrane 
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2.1.  Introduction 
As mentioned in Chapter One, the OM of Gram-negative bacteria, which is essential for 
survival, is an architecturally complex structure comprising an asymmetric bilayer that functions 
as a highly effective permeability barrier (1-3).  The OM asymmetric bilayer cannot self-assemble 
but instead results from the operation of several sophisticated machines that span three 
compartments: the IM, the periplasm, and the OM itself.  LPS, which is located exclusively in the 
outer leaflet of the OM, is the single most important determinant of the permeability barrier (3).  
LPS is placed on the cell surface by a translocon comprising two proteins, LptD and LptE (4, 5).  
LptD is a β-barrel protein that is folded and inserted into the outer membrane by the Bam machine 
(6); LptE is an OM lipoprotein that is sorted to the inner leaflet of the outer membrane by the Lol 
pathway (localization of lipoprotein) (7).   
The two essential OM proteins, LptD and LptE, form a tightly associated plug-and-barrel 
structure (8).  As the OM component of a seven-protein, trans-envelope structure that moves LPS 
from the IM to the OM, they serve together as the OM LPS translocon that facilitates the final 
insertion of LPS to the outer leaftlet of the OM (8-10).  Depletion of any of the seven Lpt proteins 
leads to accumulation of LPS in the IM (11), suggesting that LPS export thus does not progress 
beyond a very early stage unless the entire Lpt machine is intact.  How a cell assembles the seven-
protein trans-envelope complex with components in three distinct compartments is unknown.  
Even assembly of the two-protein OM LPS translocon presents a challenging problem since the 
two proteins comprising the translocon are targeted via separate pathways and must form a plug-
barrel architecture at the OM (9).  Furthermore, the formation of proper disulfide bonds is required 
for this translocon to function (9).  
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This chapter describes our efforts in elucidating the oxidative assembly pathway of the OM 
LPS translocon, showing how cells use disulfide bond formation to coordinate LPS transport 
function with other processes in OM biogenesis.  Using methods to identify different oxidized 
forms of LptD, we have extensively characterized its in vivo folding and assembly pathway in 
wild-type E. coli, and have studied a set of mutants containing defects in translocon assembly.  We 
identified and characterized seven intermediates along the folding and assembly pathway of the 
translocon.  In collaboration with Dr. Hiroshi Kadokura from the Beckwith Group, and Dr. Shu 
Sin Chng and Aaron Garner from our group, we demonstrate that a species with non-functional 
disulfide bonds that accumulates in mutants of defective LptD or LptE is an intermediate along 
the biogenesis of the LPS translocon.  We further show that the rate limiting step of the biogenesis 
pathway is the folding and assembly of this intermediate.  We also demonstrate that DsbA, a 
periplasmic oxidase, participates in this pathway during two different stages.  This pathway 
includes unanticipated mechanisms for the formation of correct disulfide bonds in a protein.  
 
2.2.  Results and Discussion 
2.2.1  A non-native disulfide-bonded intermediate (1) is observed during oxidative folding of 
LptD in vivo 
 As mentioned in Chapter One, E. coli LptD contains an N-terminal periplasmic domain 
(a.a. 25-202) and a C-terminal integral membrane β-barrel domain (a.a. 203-784) (9), which is 
folded and inserted into the OM by the Bam complex (β-barrel assembly machine) (12-14).  LptD 
has four cysteines, two in the N-terminal domain at positions 31 and 173, and two very near the 
C-terminus at positions 724 and 725 (Fig. 2.1).  In its mature form, LptD contains two long-range 
non-consecutive disulfide bonds connecting the N- and C-terminal domains, one between the first 
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and third cysteines (Cys31-Cys724 or [1-3]), and the other between the second and fourth cysteines 
(Cys173-Cys725 or [2-4]) (Fig. 1 and 2A) (15).  However, either of these two disulfides is sufficient 
for LptD to function (15).   
 
 
Figure 2.1.  The Lpt machinery forms a trans-envelope bridge that exports LPS to the cell surface 
(10).  LptBFGC forms an ABC transporter that releases LPS from the periplasmic side of the IM 
using ATP hydrolysis.  LptD and LptE form the OM LPS translocon that inserts LPS into the outer 
leaflet of the OM.  LptA presumably connects the IM ABC transporter to the OM LPS translocon, 
providing a path for LPS transit across the periplasm. LptD contains two non-consecutive disulfide 
bonds formed between its four cysteine residues as indicated. 
 
To identify mechanisms that might trigger assembly of the functional OM LPS translocon, 
we examined the genesis of mature [1-3][2-4]-LptD and asked whether it would be possible to 
detect intermediate LptD species in vivo.  Since we knew that LptE is required to produce mature 
LptD (15), we assumed it might be possible to accumulate an intermediate when LptE is the 
limiting reagent.   Depletion of LptE results in cell death, so we chose to study LptD oxidation in 
viable strains that produce much lower levels of LptE compared to wild-type cells (Fig. 2.2) (5).   
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Figure. 2.2.  A previously-reported LptE-limiting strain (5) makes different levels of LptE protein 
(lower than the wild-type strain) at various stages of growth even under non-depletion conditions.  
α-LptE immunoblot analysis of whole cell lysates obtained from wild-type (wt) or the LptE-
limiting strain.  Cells were sampled at early-, mid- and late-log phase (OD600 ~ 0.25, 0.5 and 0.9 
respectively).  Positions of relevant molecular weight markers are indicated in kDa. 
 
OM fragments isolated from wild-type cells contain only mature LptD, which migrates 
more slowly during SDS-PAGE than reduced LptD (Fig. 2.3A) (15, 16).  In contrast, OM 
fragments from the LptE-limiting strain contain a new LptD species.  In the absence of β-
mercaptoethanol, this species migrates slightly faster than fully reduced LptD, suggesting that it is 
a disulfide-bonded form of LptD (Fig. 2.3A, compare lanes 1 and 2 with lanes 3 and 4).  To assign 
the disulfide connectivity of this LptD species (intermediate 1), we examined the SDS-PAGE 
migration patterns of the six LptD mutant proteins in which two of the cysteines were changed to 
serine (15). As might be expected for a protein containing only one disulfide between adjacent 
residues Cys724 and Cys725 ([3-4]) in the C-terminus, the mutant lacking the first two cysteines 
(LptDSSCC) runs at the same position as reduced LptD (Fig. 2.4). Like wild-type LptD (LptDCCCC), 
the other LptD mutants lacking two cysteines but are able to make disulfide bonds between the N- 
and C-terminal domains (e.g. LptDSCSC and LptDCSCS) display slower mobility than reduced LptD 
on a gel (Fig. 2.4) (15). Only the mutant lacking the last two cysteines (LptDCCSS), which can make 
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the Cys31-Cys173 ([1-2]) disulfide bond within the N-terminal domain, exhibits faster mobility than 
reduced LptD (Fig. 2.3B and Fig. 2.4).  Based on these results, we concluded that the LptD 
intermediate 1 that accumulates when LptE is limiting contains the consecutive [1-2] disulfide 
bond.  As metioned below (section 2.2.6), intermediate 1 may also contains the other consecutive 
[3-4] disulfide bond.  Thus, the presence of LptE is required for the conversion of this intermediate 
to LptD with its native disulfide bonds. 
 
 
Figure 2.3.  An LptD species containing non-functional disulfide bond is accumulated when LptE 
is limiting.  (A) α-LptD and α-LptE immunoblot analyses of OM fragments obtained from wild-
type cells (wt) or cells expressing low levels of LptE.  OM fragments were isolated from cells 
grown to early-log phase (see Fig. 2.2).  Three times more membranes from cells expressing low 
levels of LptE were loaded.  Disulfide connectivity for each LptD species is shown on the right.  
(B) α-LptD and α-LptE immunoblot analyses of OM fragments obtained from wt cells expressing 
a second copy of LptD from a plasmid (p(lptDCCCC) or p(lptDCCSS)).   
 
 
 
Figure. 2.4.  The LptDCCSS double cysteine-less mutant protein migrates slightly faster than 
reduced LptD during non-reducing SDS-PAGE.  α-His immunoblot analysis of OM fragments 
obtained from wild-type cells expressing LptDSSCC-His, LptDSCSC-His, LptDCSCS-His or 
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LptDCCSS-His (15).  Where indicated, β-mercaptoethanol (β-ME) was used to reduce disulfide 
bonds. 
 
2.2.2.  Intermediate 1 is “on-pathway” to mature LptD 
 To determine whether the consecutive disulfide-bonded [1-2][3-4]-LptD (intermediate 1) 
represents an on-pathway intermediate species produced during the assembly of mature LptD in 
the membrane, or a dead-end species that falls off-pathway as a product of the cellular condition 
where LptE is the limiting reagent, we carried out pulse-labeling experiments in a wild-type strain.  
We pulse-labeled FLAG3-tagged LptD with [
35S]-methionine and monitored its progression to the 
mature form during a cold methionine chase.  The predominant form at the start of the chase is [1-
2][3-4]-LptD (intermediate 1), which is slowly converted to the mature [1-3][2-4]-LptD species 
over time (Fig. 2.5A).  Intermediate 1 cannot be chemically modified by thiol alkylating agents 
(e.g. poly(ethylene glycol) conjugated to maleimide, Fig. 2.5B), consistent with its having both 
the [1-2] and [3-4] disulfide bonds.  The final distribution of LptD species at the end of the chase 
(~20 min) is identical to that at steady state, as detected in OM fragments (Fig. 2.6).  This 
experiment establishes the intermediacy of a non-native disulfide-bonded species (intermediate 1; 
[1-2][3-4]-LptD) along the oxidative folding pathway of LptD in vivo.  Furthermore, the results 
imply that formation of the mature [1-3][2-4]-LptD species proceeds via disulfide bond 
rearrangement. 
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Figure 2.5.  LptD containing the non-native Cys31-Cys173 ([1-2]) and Cys724-Cys725 ([3-4]) 
disulfide bonds (intermediate 1) is an intermediate along the LptD assembly pathway in vivo.  (A) 
[35S]-Met pulse-chase of newly-synthesized LptD-FLAG3 in a wild-type background.  Wild-type 
cells expressing LptD-FLAG3 were pulsed for 2 min with [
35S]-methionine and chased with cold 
methionine.  The samples were NEM-alkylated, immunoprecipitated with α-FLAG antibody, and 
analyzed by SDS-PAGE/autoradiography.  (B) Maleimidyl-PEG (Mal-PEG12k) alkylation of 
[35S]-labeled intermediate 1 ([1-2][3-4]-LptD) from (A).  Where indicated, β-mercaptoethanol (β-
ME) or dithiothreitol (DTT) was used to reduce disulfide bonds.  Positions of relevant molecular 
weight markers are indicated in kDa. 
 
 
Figure. 2.6.  LptD containing the non-consecutive Cys173-Cys725 ([2-4]) disulfide bond 
accumulates in the absence of DsbA.  α-LptD Immunoblot analysis of OM fragments obtained 
from wt, ΔdsbA and ΔdsbC cells grown in rich (LB) or minimal media (M63/glc).  OM fragments 
from lptDSCSC and lptDCSCS (15) were loaded as position markers for LptD species containing either 
the Cys173-Cys725 ([2-4]) or Cys31-Cys724 ([1-3]) disulfide bonds, respectively. 
 
2.2.3.  Folding of the β-barrel domain is slow and precedes disulfide bond rearrangement  
The Bam machine must assemble the β-barrel domain of LptD in the OM compartment 
(12-14).  We asked whether formation of the disulfide bonds in mature LptD occurs before β-barrel 
folding, or vice versa.  To address this question, we performed pulse-chase experiments under 
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different conditions that do not denature a folded β-barrel so we could analyze the folded states of 
the disulfide-bonded LptD species.  Two different measures of structure have been developed for 
β-barrel proteins; folding of β-barrel membrane proteins can be followed by detecting changes in 
SDS-PAGE mobility upon heat denaturation (heat modifiability) or by monitoring protease 
susceptibility (9).  Using a “seminative” SDS-PAGE, we observed that without heating, the β-
barrel domain of wild-type mature [1-3][2-4]-LptD remains folded and the protein migrates as a 
broad band that has faster gel mobility than the unfolded mature form (Fig. 2.7A, compare wt “–” 
with “+” heat) (9).  The amount of folded [1-3][2-4]-LptD increases with time (beginning around 
t = 2 min) and persists throughout the chase.  Interestingly, a new long-lived fast-migrating LptD 
species, appearing at t = 0 min and chasing away by t = 20 min, can be detected (Fig. 2.7A, wt “–” 
heat, double open arrowhead).  This species is also heat modifiable (absent in wt “+” heat) and it 
runs at the same position as the major band in the LptDCCSS sample containing the [1-2] disulfide 
bond (Fig. 2.7A, lptDCCSS “–” heat, double asterisks).  We assign this LptD species as intermediate 
1 ([1-2][3-4]-LptD) containing a folded β-barrel.  Since the folded form of intermediate 1 chases 
to folded mature [1-3][2-4]-LptD, we conclude that the Bam machine folds the β-barrel domain of 
LptD before the disulfide rearrangement occurs.  Because this [1-2][3-4]-LptD species never 
substantially accumulates during the chase, we conclude that folding is slower than rearrangement.  
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Figure 2.7.  Folding of the LptD β-barrel domain is slow and precedes disulfide bond 
rearrangement.  (A) Seminative [35S]-Met pulse-chase of newly-synthesized LptD-FLAG3 in a 
wild-type background.  Samples were processed using non-denaturing conditions and analyzed by 
seminative SDS-PAGE that preserve (- heat) or denature (+ heat) the β-barrel fold.  Pulse-labeled 
LptDCCSS-FLAG3 was used as a control to indicate the positions of unfolded (asterisk) and folded 
(double asterisks) LptD containing the [1-2] disulfide bond.  (B) Samples from (A) were subjected 
to limited trypsin digestion and analyzed by denaturing SDS-PAGE.  Graphical representations of 
LptD species before or after trypsin digestion are shown on the right. 
 
To provide further evidence that folding and membrane insertion of [1-2][3-4]-LptD 
precedes disulfide bond rearrangement, we examined susceptibility of LptD to trypsin digestion 
during pulse-chase.  We observed that a stable fragment resistant to trypsin digestion appears early 
during the chase, and disappears with the concomitant appearance of a second slightly larger 
trypsin-stable fragment (Fig. 2.7B) (9).  The time-dependent appearance of the two trypsin-stable 
fragments is consistent with formation first of a folded intermediate 1 creating a trypsin-resistant 
49 
 
β-barrel domain ((β)-intermediate 1) which, because it does not contain disulfide bonds that 
connect the N- and C- domains of LptD (see Fig. 2.7B, right), is of smaller size than the LptD 
fragment ((β)-mature) produced by treatment with trypsin after disulfide bond rearrangement.  
Again it can be seen that the trypsin fragment produced from the intermediate 1 ([1-2][3-4]-LptD) 
does not accumulate substantially, suggesting that rearrangement of the folded [1-2][3-4]-LptD to 
folded [1-3][2-4]-LptD is faster than folding of the unfolded [1-2][3-4]-LptD.  Our studies have 
established that the rate-determining step in translocon assembly is folding of LptD into a β-barrel.  
Folding is remarkably slow, taking approximately 20 minutes, or one-third of the cell cycle, under 
the conditions studied (growth in minimal media at 37 oC).  Typical β-barrel proteins such as LamB 
fold several orders of magnitude faster than LptD (17).  LptD folding may be slow because the 
protein must wrap around LptE, forming a β-barrel that also contains a plug (8, 9).   
 
2.2.4.  Wild-type LptD can only assemble efficiently if folding proceeds through intermediate 
1 
 Disulfide bonds in E. coli envelope proteins are introduced by the periplasmic oxidase 
DsbA (18).  LptD has previously been shown to be a substrate of DsbA (19) and oxidation of LptD 
is impaired in strains lacking DsbA (15, 16).  Given that the formation of mature [1-3][2-4]-LptD 
proceeds via intermediate 1 ([1-2][3-4]-LptD), we sought to elucidate the role of DsbA in 
introducing the initial non-native disulfide bonds in LptD.  Cells lacking DsbA grown in minimal 
media accumulate mainly reduced LptD in the OM at steady state but also produce a small amount 
of an LptD species (intermediate 2) containing only the [2-4] disulfide bond (Fig. 2.6 and 2.8A).   
When we [35S]-pulse-label this same strain, newly-synthesized LptD remains in a reduced state 
throughout the chase with only a small amount of intermediate 2 appearing (Fig. 2.8B).  
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Furthermore, reduced LptD that accumulates in the absence of DsbA can be completely alkylated 
(Fig. 2.8C), indicating that all four Cys remain as free thiols and that the [1-2] and [3-4] disulfide 
bonds cannot be formed in the absence of DsbA.  Therefore, DsbA is required for the formation 
of intermediate 1 ([1-2][3-4]-LptD).  In fact, neither intermediate 1 nor mature LptD is detected in 
these experiments (Fig. 2.8A and B).  Although cells lacking DsbA do make a small amount of a 
functional LptD (intermediate 2; [2-4]-LptD), these cells do not grow well.  It is clear that without 
formation of the [1-2][3-4]-LptD intermediate, the pathway to form mature [1-3][2-4]-LptD is 
extremely inefficient. 
 
Figure 2.8.  DsbA is required for efficient assembly of mature LptD through intermediate 1.  (A) 
α-FLAG immunoblot analysis of OM fragments obtained from wt and ΔdsbA strains containing 
pET23/42lptD-FLAG3 grown in minimal media.  Disulfide connectivity for relevant LptD species 
is shown on the right.  (B) [35S]-Met pulse-chase of newly-synthesized LptD-FLAG3 in a ΔdsbA 
background.  (C) Maleimidyl-PEG (Mal-PEG12k) alkylation of [35S]-labeled reduced-LptD from 
(B).  Bands denoted by asterisks represent LptD degradation products. 
 
2.2.5.  A disulfide bond between Cys724 and Cys725 ([3-4]) is likely formed in intermediate 1 
To determine if the [3-4] disulfide bond is formed, we examined whether the cysteines in 
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intermediate 1 could be labeled by thiol-alkyating agents.  Intermediate 1 cannot be chemically 
modified by maleimidyl-poly(ethylene glycol) (Mal-PEG) unless it has been pre-treated with 
reducing agent DTT (Fig. 2.5B and 2.8C).  To rule out the possibility that the 3rd and 4th cysteines 
in intermediate 1 were not reactive due to steric inaccessibility (even under reducing conditions), 
we also performed alkylating experiments with the C-terminal domain of LptD (C-LptD) alone, 
which contains only these two cysteines.  We found that the C-LptD protein can be modified by 
Mal-PEG when pre-treated with DTT (Fig. 2.9A).  Taken together, these results suggest that 
intermediate 1 likely contains both the [1-2] and [3-4] disulfide bonds.   
Intermediate 1 must convert to [2-4]-LptD during oxidative assembly of LptD (Fig. 2.5A).  
If intermediate 1 contains both the [1-2] and [3-4] disulfide bonds, one of these bonds would need 
to be reduced prior to rearrangement to the [2-4] bond.  To determine if the periplasmic disulfide 
isomerase DsbC could serve as a reductant in the pathway, we conducted pulse-chase experiments 
to follow the biogenesis of wild-type LptD proteins in a strain lacking DsbC.  We found that 
removing DsbC significantly slows down the rate of disulfide bond rearrangement from 
intermediate 1 to the mature form of wild-type LptD (Fig. 2.9B); in the presence of DsbC, this 
conversion takes ~20 min (Fig. 2.5A), while in the absence of DsbC, it takes ~2-3 times (40-60 
min) longer (Fig. 2.9B).  We also examined the biogenesis of the LptDCCSC mutant protein in the 
absence of DsbC, and found that the rate of disulfide bond rearrangement from the [1-2]-LptDCCSC 
species to the [2-4]-LptDCCSC species now occurs ~20 min (Fig. 2.9C), comparable to the 
rearrangement in wild-type LptDCCCC in the presence of DsbC (Fig. 2.5A).  Since the LptDCCSC 
does not (cannot) contain the [3-4] bond, these data suggest that DsbC may be involved in reducing 
that disulfide bond in wild-type intermediate 1 (likely [1-2][3-4]-LptD) in order to allow 
rearrangement to take place.   
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Fig. 2.9.  A disulfide bond between Cys724 and Cys725 may be formed in intermediate 1.  (A) 
Maleimidyl-PEG (Mal-PEG5k) alkylation of C-LptD-FLAG3 in a wild-type background.  (B) 
[35S]-Met pulse-chase of newly-synthesized LptD-FLAG3 in a ΔdsbC background.  (C) [35S]-Met 
pulse-chase of newly-synthesized LptDCCSC-FLAG3 in a ΔdsbC background.  Where indicated, β-
mercaptoethanol (β-ME) or dithiothreitol (DTT) were used to reduce disulfide bonds.   
 
The assumption that the [3-4] disulfide bond forms in this pathway remains an open 
question.  Whether the [3-4] bond exists, however, does not affect our proposed pathway (since 
subsequent reduction of this disulfide bond is a prerequisite for rearrangement).  It is also true that 
while we were able to observe DsbA adducts responsible for the formation of [1-2] and [1-3] 
disulfide bonds (Fig. 2.10), we were not able to detect a DsbA adduct (with either the 3rd or 4th Cys 
of LptD) that would allow formation of the [3-4] disulfide bond.   
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2.2.6.  LptD intermediates containing mixed-disulfide adducts with DsbA can be detected in 
vivo allowing the complete oxidative folding pathway for LptD to be delineated   
 We used a DsbAP151T mutant that forms kinetically stable mixed-disulfide intermediates 
with substrate proteins to see if we could accumulate cross-linked adducts between LptD and DsbA 
(19).  We observed two LptD species that also contain DsbA (Fig. 2.10A).  These new bands can 
be assigned as mixed-disulfide intermediates linking DsbA to Cys31 of reduced LptD (DsbA adduct 
A; [1-DsbA]) and to Cys31 of [2-4]-LptD (DsbA adduct B; [2-4][1-DsbA]) by comparing to 
adducts observed with LptD using Cys-to-Ser mutants (Fig. 2.10A, C and 2.11).  DsbA adduct A 
likely corresponds to the first-formed intermediate between LptD and DsbA leading to the 
formation of the [1-2] disulfide bond (Fig. 2.10C).  In fact, when pulse-chase analysis is carried 
out in the dsbAP151T strain, we detect [
35S]-labeled DsbA adduct A at early time points (t = 0-2 min, 
Fig. 2.10B), consistent with this interpretation.  We also observe the appearance of DsbA adduct 
B ([2-4][1-DsbA]-LptD) at t = 2 min, which chases by t = 40 min.  The fact that this species 
appears before (and chases into) final mature LptD ([1-3][2-4]-LptD) is strong evidence that DsbA 
adduct B is also a true species along the assembly pathway and suggests that DsbA directly 
introduces the [1-3] disulfide bond in LptD after the [2-4] disulfide is already formed (Fig. 2.10C).  
Therefore, DsbA makes both the [1-2] and the [1-3] disulfide bonds in LptD at different stages of 
assembly. 
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Figure 2.10.  LptD intermediates containing mixed-disulfide adducts with DsbA can be detected 
in vivo.  (A) α-FLAG immunoprecipitation using wt or dsbAP151T cells containing pET23/42lptD-
FLAG3.  Samples were analyzed by α-FLAG and α-DsbA immunoblots.  (E) [35S]-Met pulse-chase 
of newly-synthesized LptD-FLAG3 in wt and dsbAP151T backgrounds.  (C) The seven intermediate 
LptD species observed experimentally (including the final mature form) are depicted as they 
appear after secretion across the IM during oxidative assembly of the OM LPS translocon.  The 
precursor of LptD (pre-LptD) containing its signal peptide (prior to secretion) is also shown.  
Introduction of the [3-4] disulfide bond, presumably following [1-2] disulfide formation, is likely 
also dependent on DsbA. 
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Fig. 2.11.  The dsbAP151T mutation results in the accumulation of mixed-disulfide adducts between 
DsbA and Cys31 of LptD.  α-FLAG immunoprecipitation using dsbAP151T cells containing 
pET23/42lptD-FLAG3 or single/double Cys mutants.  Samples were analyzed by α-FLAG and α-
DsbA immunoblot under non-reducing conditions.  All LptD Cys mutant proteins that contain 
Cys31 can be trapped in an intermediate with DsbA ([1-DsbA]-LptD, closed red arrowheads).  The 
LptDCCSC and LptDCCCS proteins are also trapped in a second DsbA adduct via Cys31.  LptDCCSC 
exists predominantly as [2-4]-LptD in a wild-type dsbA background (15), which becomes cross-
linked to DsbA in a dsbAP151T background ([2-4][1-DsbA]-LptD, open red arrowhead).  In addition 
to [1-3]-LptD, LptDCCCS also exist as [2-3]-LptD in a wild-type DsbA background (15), which 
becomes cross-linked to DsbA in a dsbAP151T background ([2-3][1-DsbA]-LptD, double asterisks).  
Single asterisks denote degradation products from LptD containing one disulfide bond. 
 
 The ability to detect several DsbA adducts with LptD during pulse-chase allows us to 
describe the sequence of events leading to the assembly of a functional OM LPS translocon.  Taken 
together we can assign seven distinct species along the oxidative folding pathway of LptD in vivo 
(Fig. 2.10C).  The first non-consecutive disulfide bond is formed between Cys173 and Cys725 ([2-
4]), presumably via reduction of one of the consecutive disulfides of [1-2][3-4]-LptD, followed by 
disulfide bond rearrangement.  Since it has been established that either of the two non-consecutive 
disulfide bonds is sufficient for the proper function of LptD (15), the [2-4]-LptD species 
(intermediate 2) represents the first functional form of LptD assembled in the cell.  In this regard, 
it is important to point out that cysteines corresponding to both Cys173 and Cys725 are present in 
>95% of over one thousand Gram-negative LptD proteins that have non-identical sequences (Fig. 
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2.12, 16), suggesting that the [2-4] disulfide bond plays a critical structural role in the function of 
the OM LPS translocon. 
 
 
Fig. 2.12.  Cys173 and Cys725 are very highly conserved among LptD homologs.  (A) 
Conservation of the four cysteine residues in E. coli LptD across 1056 LptD homologs that are 
non-identical.  (B) Sequence alignments of 32 LptD homologs that are <30% identical depicting 
only the regions around the cysteine residues in E. coli LptD.  E. coli LptD is shown in green. 
 
2.2.7.  Disulfide rearrangement of intermediate 1 is triggered by LptE to activate the OM 
translocon for LPS export  
We have shown that LptD accumulates in the form of intermediate 1 ([1-2][3-4]-LptD) 
when LptE is limiting (Fig. 2.3A).  Restoring LptE levels should rescue this defect by allowing 
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the conversion of the accumulated [1-2][3-4]-LptD species to mature LptD.  We discovered that a 
previously described LptE-depletion strain produces increasing levels of LptE as the cells progress 
through exponential growth phase (Fig. 2.4) (5).  This offers the possibility for us to watch how 
LptD assembly progresses as LptE levels increase.  At early log phase, LptD intermediate 1 
accumulates because LptE levels are limiting (Fig. 2.3A and 2.13A).  As we examined these cells 
at mid-log phase, when levels of LptE have increased substantially, we observed a corresponding 
conversion of previously accumulated intermediate 1 to the mature LptD species (Fig. 2.13A).  As 
a component of the LptD/E complex, LptE is, by definition, required for the formation of the non-
functional OM LPS translocon (intermediate 1/LptE, “INACTIVE” state) in the OM (Fig. 2.13C).  
Our results show that by changing the levels of LptE, the cell can also control the levels of activated 
translocon ([1-3][2-4]-LptD/E, “ACTIVE” state) in the OM.  Therefore, assembly of the LptD/E 
complex controls activation of the translocon; only when the non-functional OM translocon is 
properly formed does disulfide bond rearrangement take place efficiently to activate LPS transport 
at the OM (Fig. 2.13C).   
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Figure 2.13.  Formation of the mature functional OM LPS translocon proceeds via pre-assembly 
of a non-functional LptD/E intermediate that is activated via disulfide bond rearrangement.  (A) α-
LptD and α-LptE immunoblot analyses of OM fragments obtained from cells that express different 
levels of LptE according to the growth phase.  OM fragments were isolated from cells grown to 
early-log phase (low LptE) and mid-log phase (high LptE) (see Fig. 2.4).  (B) α-LptD and α-LptE 
immunoblot analyses of OM fragments obtained from wt, lptDΔ330-352, lptEΔ100-101/P99R and lptDΔ529-
538 strains.  Open arrowheads indicate the position of [1-2][3-4]-LptD in each strain.  (C) Folding 
(pre-assembly) and rearrangement (activation) of the OM LPS translocon coordinate all three OM 
biogenesis pathways (Bam, Lol, and Lpt) so that they converge on the single most important 
process, LPS export, in establishing the barrier function of the OM. 
 
2.2.8.  OM LPS translocon mutants have defective triggering mechanisms  
We have shown that the maturation of a functional OM LPS translocon is a two-step 
process involving a folding/insertion step followed by disulfide rearrangement.  Useful mutants 
having defects in the OM LPS translocon have proven difficult to isolate.  The first, identified 
more than twenty years ago, contains a 23-amino acid deletion (Δ330-352) in the β-barrel domain 
of LptD (LptDΔ330-352, known as LptD4213) (20).  Since that time very few other useful mutants 
have been reported.  One contains a 10-amino acid deletion (Δ529-538) in the LptD β-barrel 
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(LptDΔ529-538) (8), and another contains a two-amino acid deletion (Δ100-101/P99R) in LptE 
(LptEΔ100-101/P99R) (21). We analyzed the LptD oxidation states for all three mutants in the OM 
fractions and found that each of the mutations results in substantial accumulation of intermediate 
1 ([1-2][3-4]-LptD) (Fig. 2.13B), similar to what occurs under LptE-limiting conditions (Fig. 2.3A 
and 2.13A).  Therefore, for these three mutants, progression along the oxidative folding pathway 
of LptD from intermediate 1 to the mature form is arrested.  Since the disulfide bonds in the mature 
form of LptD are between pairs of cysteines that are far apart on the primary sequence of the 
protein (Cys31-Cys724 and Cys173-Cys725), conversion of intermediate 1 ([1-2][3-4]-LptD) to 
mature LptD ([1-3][2-4]-LptD) likely requires that all the cysteines be in close spatial proximity.  
Inefficient formation of mature LptD in the mutants suggests that the alignment of the non-native 
disulfides in intermediate 1 is not optimal.  In fact, we can show that with one of the LptD mutants 
(LptDΔ330-352), LptD still interacts with LptE (Fig. 2.14).  This mutant LptD can fold and assemble 
with LptE to form the non-functional intermediate 1 (“INACTIVE” state) in the OM, but it appears 
as though the cysteines are not correctly positioned for rearrangement to activate the translocon. 
 
Fig. 2.14.  The [1-2][3-4]-LptDΔ330-352 mutant protein can assemble with LptE, but is defective in 
disulfide bond rearrangement to form mature LptD.  Ni-NTA affinity purification using wt or 
lptDΔ330-352 cells containing pET23/42lptE-His.  Samples were analyzed by α-LptD and α-His 
immunoblots. 
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Producing nonfunctional intermediate 1 before activation via disulfide bond rearrangement 
also provides a mechanism for quality control to ensure that the trans-envelope LPS exporter is 
assembled with only a functional OM translocon.  Proper disulfide bonds in LptD are required for 
the trans-envelope Lpt bridge to form via interactions between LptA and LptD (22). The triggering 
strategy prevents a defective OM translocon from achieving the correct disulfide bond 
configuration, thereby preventing formation of a nonfunctional trans-envelope LPS exporter that 
might release LPS into an inappropriate compartment. 
 
2.3. Conclusion and Future Work 
In this chapter, we extensively characterized the biogenesis pathway of LptD.  LptD has 
two non-consecutive disulfide bonds ([1,3] and [2,4]) that connect the N-terminal periplasmic 
domain to the C-terminal β-barrel domain in the mature form (15).  A non-functional disulfide 
bonded species of LptD, [1,2][3,4]-LptD accumulates when LptE is limiting.  This [1,2][3,4]-LptD 
also accumulates when there are defects in LptD or LptE.  We demonstrate that this species is an 
on-pathway intermediate towards the assembly of LPS translocon, and the folding of this species 
by the Bam machine is the rate determining step of the biogenesis pathway of the LptD/E complex.  
We also show that although this [1,2][3,4]-LptD is not a required intermediate towards function 
translocon in mutants like dsbA-, the efficiency of translocon assembly is largely deterred when 
this intermediate is not able to form.  Using a mutant that allows accumulation of DsbA-substrate 
during oxidation, we demonstrate that two separate oxidation steps by the periplasmic oxidase 
DsbA take place during the assembly of the LptD/E complex.  DsbA is required for the formation 
of [1,2][3,4]-LptD in the periplasm and, later at the OM after disulfide rearrangement, to make the 
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[1,3] disulfide bond.  Given that a functional translocon with proper disulfide bond is a prerequisite 
to the formation of the seven-protein trans-envelop LPS transporter, the oxidative assembly 
pathway of LptD ensures that only the functional translocons are employed to form the Lpt 
machine.   
To understand the molecular mechanism of how the LPS translocon functions requires 
detailed structural information of the complex.  Dr. Goran Malojcic and Aaron Garner have been 
working closely to obtain X-ray crystallographic information of the β-barrel structure of the 
LptD/E complex.  In lieu of a molecular structure, Dr. Suguru Okuda, a former postdoc in our 
group and Alex George have appled the photo-activatable unnatural amino acid crosslinking 
technique to capture LPS molecules that are being transported by the translocon on their way to 
the final destination.   
Our long-term goal is to understand Bam-mediated assembly of β-barrel proteins (6).  LptD 
is an important substrate for the Bam machine since it is the only essential β-barrel protein in E. 
coli besides BamA, the β-barrel component of the Bam complex itself.  We propose that LptD 
would be an ideal system in which to study β-barrel assembly in vivo since seven intermediates 
have been identified along its assembly pathway (see Chapter Three).  Additionally, LptD β-barrel 
folding is extremely slow and precedes disulfide rearrangement; this allows us to monitor folding 
intermediates during β-barrel folding using different disulfide-bonded states.  Our ability to 
visualize and accumulate different oxidation states of LptD allows us to extend to membrane 
proteins the classic approach of using disulfide bonds to study the folding of soluble proteins in 
vivo (23, 24). Combined with our in vitro reconstitution of Bam-mediated folding (25), it may be 
possible to dissect β-barrel protein folding into individual steps.  It is too early to tell whether it 
will be possible to use the information concerning assembly of the translocon to break the machine 
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responsible for LPS export.  We are encouraged by the fact that small molecules that target LptD 
in Pseudomonas aeruginosa have recently been described (26).  Given the slow rate of LptD 
folding, we might be able to design inhibitors against the long-lived non-functional states of the 
OM LPS translocon, and thus prevent its activation. 
 
2.4. Materials and Methods 
2.4.1. Bacterial strains 
For most experiments, the wild-type strain used is MC4100 [F- araD139 Δ(argF-lac) U169 
rpsL150 relA1 flbB5301 ptsF25 deoC1 ptsF25  thi].  The LptE-depletion strain used that makes 
varying levels of LptE according to growth phase is AM689 [MC4100 ara+ lptE::kan λatt(PBAD-
lptE)] (5).  The lptDΔ330-352 (lptD4213), lptEΔ100-101/P99R (lptE6) and lptDΔ529-538 mutant strains used 
are NR698 (20), GC190 [MC4100 ara+ ΔlptE2::kan pBAD18lptE] (21) and MC4100 ΔlptD2::kan 
pET23/42lptDΔ529-538 (8), respectively.  The ΔdsbA and ΔdsbC strains used are NR1216 and 
NR1217 (15), respectively.  For experiments involving the dsbAP151T mutant, the wild-type strain 
used is HK295, a MC1000 derivative [F- Δara714 galU galK Δ(lac)X74 rpsL thi] and the dsbAP151T 
mutant used is HK348 [HK295 zin::Tn10 dsbAP151T] (19).  Luria-Bertani (LB) broth and 
M63/glucose minimal broth and agar were prepared as described previously (27).  Arabinose (0.2% 
w/v) was added for the growth of AM689 (5) and GC190 (21).  Growth of strains was carried out 
at 37 oC unless explicitly indicated.  When appropriate, kanamycin (25 μg/ml) and carbenicillin 
(50 μg/ml) were added.  Amino acids were added at 50 μg/ml when indicated. 
 
2.4.2.  Plasmid construction 
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To construct pET23/42lptD-FLAG3, a cassette containing the coding sequence of the 
FLAG3 tag was inserted into pET23/42lptD-His (5) to replace the original His8 tag.  Briefly, the 
entire pET23/42lptD-His template was amplified by PCR (using primers 5’-
AGATCATGATATCGACTATAAAGACGATGATGACAAATAATTGATTAATACCTAGGCTGC-3’ 
and 5’-ATAGTCGATATCATGATCTTTGTAGTCGCCGTCGTGATCTTTATAATCGCGCGCCAAG 
GC-3’) and the resulting PCR product mixture digested with DpnI for > 1 h at 37 oC.  NovaBlue 
(Novagen) cells were transformed with 1 μl of digested PCR product and plated onto LB plates 
containing 50 μg/ml carbenicillin.  For each construct, plasmids from six colonies were isolated 
and sequenced. 
 To generate LptD Cys mutant constructs containing the FLAG3 tag, pET23/42lptDXXXX-
His constructs were first made via site-directed mutagenesis using relevant primers (15) and 
pET23/42lptD-His (5) as the initial template.  Briefly, the entire template was amplified by PCR 
and the resulting PCR product mixture digested with DpnI for > 1 h at 37 oC.  NovaBlue (Novagen) 
cells were transformed with 1 μl of digested PCR product and plated onto LB plates containing 50 
μg/ml carbenicillin.  For each construct, plasmids from six colonies were isolated and sequenced.  
The resulting pET23/42lptDXXXX-His constructs were used in the same protocol above to generate 
pET23/42lptDXXXX-FLAG3 constructs. 
 
2.4.3.  Growth of AM689 for OM analysis 
10-ml cultures were grown overnight at 30 oC in LB broth containing 0.2% arabinose.  
Cultures were pelleted and washed twice in equal volume of LB broth.  Fresh LB cultures (1.5-l) 
either containing 0.2% arabinose were inoculated with the washed cells to an initial OD600 of ~0.01 
and were grown at 30 oC until OD600 reaches ~0.25 (~4 h) and ~0.5 (~5 h).  The amount of cells 
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equivalent to that in a 500-ml culture of OD600 ~0.5 was pelleted by centrifugation at 5000 x g for 
20 min and subjected to OM analysis (see below). 
 
2.4.4.  Isolation of OM for analysis of LptD oxidation states 
Strains MC4100, AM689, NR1216, NR1217, NR698, GC190 and MC4100 ΔlptD2::kan 
pET23/42lptDΔ529-538 were used for OM analysis.  These strains contain a single copy of lptD 
expressed from the chromosome or plasmid.  Strains MC4100 containing p(lptDCCCC) or 
p(lptDCCSS) (pET23/42lptD or pET23/42lptDCCSS, respectively (15)), MC4100, NR1216, HK295 
and HK348 containing pET23/42lptD-FLAG3 were also used for OM analysis experiments.  These 
strains contain two copies of lptD, one expressed from the chromosome and the other expressed 
from pET23/42. OM analysis is performed as previously described (15).   
 
2.4.5.  Pulse-chase analysis 
Strains MC4100, NR1216, HK295 and HK348 containing pET23/42lptD-FLAG3 were 
used in pulse-chase experiments.  Pulse-chase experiments were essentially carried out according 
to published protocols (23).  Briefly, a 5-ml culture was grown to OD600 ~0.5 in M63/glucose 
minimal media supplemented with eighteen amino acids (minus methionine and cysteine) at 37 oC.  
The culture was pulse-labeled with [35S]-methionine (100 μCi/ml final concentration) (American 
Radiochemicals) for 2 min and then chased with cold methionine (5 mM) at 37 oC.  At the indicated 
time point during the chase, a 800 μl culture aliquot was transferred to a 1.5-ml tube containing 80 
μl of trichloroacetic acid (TCA, 70% in water), incubated on ice for 20 min.  Precipitated proteins 
were pelleted at 18,000 x g for 10 min at 4 oC, washed with 700 μl ice-cold acetone, and then 
solubilized in 80 μl 100 mM Tris.HCl, pH 8.0 containing 1% SDS and 20 mM N-ethylmaleimide 
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(NEM, Sigma).  The sample was sonicated for 30 s to aid solubilization.  Following that, 800 μl 
of ice-cold IP buffer (50 mM Tris.HCl, pH 8.0 containing 150 mM NaCl, 2% Triton X-100, 1 mM 
EDTA) was added and the sample was centrifuged at 18,000 x g for 10 min at 4 oC.  700 μl of the 
supernatant was transferred to another 1.5-ml tube containing 2.5 μl of anti-FLAG® M2 magnetic 
beads (Sigma).  The beads were washed and pre-equilibrated with 3 x 1 ml IP buffer before use.  
The mixture was incubated on a rotary shaker for 1 h at 4 oC, and the beads were washed with 3 x 
800 μl of ice-cold high salt buffer (50 mM Tris.HCl, pH 8.0 containing 1 M NaCl, 1% Triton X-
100, 1 mM EDTA) and 1 x 800 μl ice-cold 10 mM Tris.HCl, pH 8.0 using a magnetic separation 
rack (New Englands Biolabs).  60 μl 2X SDS non-reducing sample buffer was then added to the 
beads and the mixture heated for 10 min at 100 oC to elute the bound proteins.  15 μl of eluted 
sample was applied to SDS-PAGE directly.  For reduction of disulfide bonds, 0.5 μl β-
mercaptoethanol (β-ME, Sigma) was added to 20 μl eluted sample and heated for 5 min at 100 oC 
before loading.  4-20% Tris.HCl polyacrylamide gels were used (running conditions: 150 V for 
120 min).  The gel was then dried and exposed to phosphor storage screens for autoradiography. 
 
2.4.6.  Maleimide-PEG (Mal-PEG12k) alkylation of [35S]-pulse-labeled samples 
Alkylation was carried out according to published protocols (23).  Following the acetone 
wash step as outlined in the pulse-chase analysis protocol above, TCA-precipitated proteins were 
either directly subjected to alkylation or first reduced before alkylation.  For reduction of disulfide 
bonds, TCA-precipitated proteins were incubated in 100 μl 100 mM Tris.HCl, pH 8.0 containing 
0.1% SDS and 100 mM dithiothreitol (DTT, Invitrogen) for 30 min at room temperature.  700 μl 
M63 media was added and the reduced proteins were re-precipitated with TCA and further washed 
with acetone.  Precipitated proteins (reduced or not) were then solubilized in 80 μl 100 mM 
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Tris.HCl, pH 6.8 containing 1% SDS and 5 mM Mal-PEG12k (Sunbright ME-120MA, NOF).  The 
mixture was gently vortexed for 20 min at room temperature, and subsequently incubated for 30 
min at 37 oC.  800 μl of ice-cold IP buffer was added and the sample was subjected to 
immunoprecipitation as outlined in the pulse-chase analysis protocol.   
 
2.4.7.  Seminative pulse-chase analysis 
Strain MC4100 containing pET23/42lptD-FLAG3 was used in seminative pulse-chase 
experiments.  A 5-ml culture was grown to OD600 ~0.5 in M63/glucose minimal media 
supplemented with eighteen amino acids (minus methionine and cysteine) at 30 oC.  The culture 
was pulse-labeled with 35S-methionine (100 μCi/ml final concentration) (American 
Radiochemicals) for 2 min and then chased with cold methionine (5 mM) at 37 oC.  At the indicated 
time point during the chase, a 800 μl culture aliquot was transferred to a 1.5-ml tube and pelleted 
at 18,000 x g for 1 min at 4 oC.  The cell pellet was resuspended in 100 μl lysis buffer (20 mM 
Tris.HCl, pH 8.0 containing 150 mM NaCl, 1% SDS, 0.5 mg/ml lysozyme, 1 mM 
phenylmethylenesulfonylfluoride (PMSF, Sigma), 1 mM EDTA and 40 mM NEM).  After 
incubated for 2.5 min at room temperature, 1 ml of ice-cold IP-2 buffer (50 mM Tris.HCl, pH 8.0 
containing 150 mM NaCl, 2% n-octyl-β-glucoside (OG, Anatrace), 1 mM EDTA) was added and 
the sample was centrifuged at 18,000 x g for 30 min at 4 oC.  950 μl of the supernatant was 
transferred to another 1.5-ml tube containing 2.5 μl of anti-FLAG® M2 magnetic beads (Sigma).  
The beads were washed and pre-equilibrated with 3 x 1 ml IP-2 buffer before use.  The mixture 
was incubated on a rotary shaker for 2 h at 4 oC, and the beads were washed with 4 x 800 μl of ice-
cold wash buffer (50 mM Tris.HCl, pH 8.0 containing 1 M NaCl, 2% OG, 1 mM EDTA) using a 
magnetic separation rack (New Englands Biolabs).  30 μl of ice-cold elution buffer (50 mM 
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Tris.HCl, pH 8.0 containing 1 M NaCl, 2% OG, 1 mM EDTA, 250 μg/ml FLAG3 peptide (Sigma)) 
was then added to the beads and the mixture incubated for 10 min at 4 oC to elute the bound 
proteins.  An equal volume of 2X SDS non-reducing sample buffer was added and the sample split 
into two – one applied to seminative SDS-PAGE directly and the other heated for 10 min at 100 
oC before loading.  10% Tris.HCl polyacrylamide gels were used (Running conditions: 150 V for 
75 min, 4 oC).  The gel was then dried and exposed to phosphor storage screens for autoradiography.   
 
2.4.8.  Trypsin digestion following seminative pulse-chase experiment 
Trypsin digestion was performed according to published protocols (9).  Samples that were 
eluted off the M2 magnetic beads were treated with 50 μg/ml trypsin for 4 h at room temperature.  
An equal volume of 2X SDS non-reducing sample buffer was added and the samples heated for 
10 min at 100 oC before SDS-PAGE.  4-20% Tris.HCl polyacrylamide gels were used (running 
conditions: 150 V for 120 min).  The gel was then dried and exposed to phosphor storage screens 
for autoradiography. 
 
2.4.9.  Affinity purification 
Strains MC4100 and NR698 containing pET23/42lptE-His (9) was used in affinity 
purification experiments.  Affinity purification experiments were performed as previously 
described (9). 
 
2.4.10.  Bioinformatics 
The list of non-identical LptD sequences was collected by BLAST.  Using the E. coli LptD 
sequence as a start, an initial BLAST hit list was collected.  The weak hits were then used as the 
new reference sequence to BLAST search for more LptD sequences.  By doing this recursively for 
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over 20 rounds, thousands of LptD sequences were collected.  This initial list was then filtered to 
remove identical sequences and partial genes (usually containing deletions on one or the other end 
of the gene).  The final list contains 1056 non-identical LptD sequences.  
      
2.4.11.  Antibodies 
Monoclonal α-His conjugated to horseradish peroxidase was purchased from Qiagen.  
Monoclonal α-FLAG conjugated to horseradish peroxidase was purchased from Sigma.  α-LptD 
(16), α-LptE (9) and α-DsbA (28) antiserum were already described. 
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3.1.  Introduction 
In Chapter Two, we demonstrated that we were able to see seven intermediates along the 
biogenesis pathway of LptD, in which folding of the β-barrel is the rate-limiting step (1).  Since 
folding of the β-barrel takes ~20 min for LptD/E, we wondered if we could characterize this 
process further.  In this chapter, we study how the Bam complex folds LptD.   
One of the most important functions of the Bam complex is to fold LptD as LptD, together 
with lipoprotein LptE, facilitates the final insertion of LPS into the OM.  Among all the β-barrel 
substrates of Bam complex, only two of them are essential: BamA, the β-barrel component of the 
Bam complex itself and LptD, the β-barrel portion of the OM LPS translocon (2, 3).   
Folding of general β-barrel proteins by the Bam machinery is rapid (4).  For example, a 
typical β-barrel protein, LamB, folds in a matter of seconds (4).  The rapid nature of  this general 
folding process complicates study, since it is unlikely that folding intermediates could be observed 
during such a short time frame.  For this reason,  LptD is  an ideal substrate to study Bam assisted 
protein folding, because the long folding process greatly increases the likelihood of observing 
distinct intermediates on the Bam complex.   
Folding of LptD is a challenging task.  In its folded form, LptD forms a tight plug-and-
barrel complex with the lipoprotein LptE (5, 6). As an lipoprotein, LptE arrives at the OM via a 
separate Lol pathway.  How the two proteins that are directed to the OM by separate means fold 
into a tight complex with one sitting inside of the other poses a challenging question.   
This chapter describes our efforts to characterize Bam assisted LptD folding by studying 
folding intermediates on the Bam complex.  We employed a chemical crosslinking technique in 
both steady state and radioactive methionine pulse labeled cells to trap substrates on the Bam 
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complex.  In collaboration with two geneticists, Prof. Thomas Silhavy at Princeton University and 
Prof. Natividad Ruiz at Ohio State Univeristy, and with Dr. Joseph Wzorek in our group, we first 
demonstrated that an LptD mutant can be chemically crosslinked to BamA.  We further 
characterized this trapped LptD mutant species and found that it is a species that we have seen 
before; a species that has a characteristic [1,2] disulfide bond which indicates that it is an 
intermediate on the assembly pathway of LptD.  We demonstrated that this trapped species on the 
Bam complex is a folding intermediate when all four essential OM proteins (BamA/D, LptD/E) 
are making contacts with each other.  We also found that the lipoprotein LptE is part of the Bam 
complex when folding LptD, and it mediates the interaction between an essential Bam lipoprotein 
and LptD.  Additionally, we demonstrated that LptE and BamA can be purified as a stable complex, 
and the presence of LptE enhances the activity of the machine when folding a β-barrel substrate.  
 
3.2.  Results and Discussion 
3.2.1.  LptD and LptE can be chemically crosslinked to BamA in vivo 
LptD is a slow folding substrate on the Bam complex (1).  We wondered if it is sufficiently 
slow that we could see a folding substrate on the Bam machine.  We first analyzed the folding of 
wild-type LptD, a defective mutant lptD4213 and its intragenic suppressor lptD61 by looking at 
dithiobis[succinimidyl propionate] (DSP) crosslinking between LptD and BamA.  LptD4213 
harbors a 23 amino acid deletion in one of the putative extra-cellular loops, which results in the 
accumulation of a LptD species that has intermediary disulfide bonds (see Chapter Two) and 
lptD61 has an additional N274I mutation that restores the majority of LptD back to the functional 
form (Fig 3.1A).  DSP, a thiol cleavable crosslinking reagent, has two amine-reactive groups at 
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each end of a spacer arm that can react with proteins that physically interact.  At steady state, we 
observed little to no wild type LptD crosslinked to BamA (Fig. 3.1B, lane 1). However, a large 
amount of LptD4213 crosslinked to BamA can be found (Fig. 3.1B, lane 2).  The intragenic 
suppressor, lptD61, reduced the amount of crosslinking significantly (Fig. 3.1B, lane 3).  These 
results suggest that mutant LptD can be trapped on BamA in vivo.  
We wondered what else was also attached to BamA when LptD4213 accumulated on it.  
We found that another essential lipoprotein is associated with BamA (Fig. 3.1B); that lipoprotein 
is LptE, the lipoprotein that resides inside the lumen of the β-barrel of LptD.  It suggests that LptE 
is present on the Bam complex when folding LptD.   
Genetic evidence arising from a mutant-suppressor pair of LptE and BamA also suggests 
that LptE is involved in the Bam mediated folding of the LptD/E complex (8).  LptE6, a defective 
LptE mutant that harbors a two-amino acid deletion (Δ100-101/P99R) which causes accumulation 
of [1,2][3,4]-LptD (1, 8), can be rescued by a suppressor found in BamA (BamAP159L) (8).  How 
BamAP159L rescues LptE6 remains unknown.   
76 
 
 
Figure 3.1.  LptD and LptE can accumulates on BamA in an LptD mutant.  (A) α-LptD 
immunoblot analysis of OM fragments obtained from wt, lptD4213 and lptD61 strains.  (B) wt, 
lptD4213 and lptD61 strains expressing his-BamA were crosslinked with DSP, affinity purified 
with Ni-NTA column and analyzed by α-LptD and α-LptE immunoblot under reducing condition. 
 
3.2.2.  The chemically trapped LptD on BamA is a characterized intermediate along the LptD 
biogenesis pathway 
LptD undergoes specific oxidative rearrangement of disulfides during its biogenesis (1, see 
Chapter Two).   We wondered if the crosslinked species was a species that was slower to assemble, 
and we were crosslinking a folding intermediate.  To address this question, we investigated the 
oxidation states of the crosslinked LptD4213 species.   
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Figure 3.2.  The mutant that accumulates on BamA is a characterized intermediate on the assembly 
pathway of LptD.  wt and lptD4213 cells expressing his-BamA were crosslinked with DSP or EGS 
and affinity purified with a Ni-NTA column.  Crosslinkers were subsequently cleaved by treatment 
with β-mercaptoethanol (in the case of DSP) or hydroxylamine (in the case of EGS).  Samples are 
subjected to α-LptD and α-LptE immunoblot analyses.  Outer membrane fragment of the same 
cells are used as internal markers.  
 
In order to analyze the oxidation states of crosslinked intermediates, we switched to a 
different crosslinking reagent, ethylene glycol bis[succinimidylsuccinate] (EGS), which, unlike 
DSP, could be cleaved under non-reducing condition that allows the assessment of disulfide bond 
configurations.  We found that the trapped LptD substrates on BamA were indeed in the [1,2] 
disulfide bonded state by comparing SDS–polyacrylamide gel electrophoresis (PAGE) mobility to 
authentic standards isolated from outer membranes of respective strains (Fig. 3.2).  This shows 
that the accumulated species that we trapped on BamA is an intermediate that we have observed 
before (see Chapter Two) (1).  It is a species that is an intermediate on the assembly pathway of 
LptD and it has not yet finished assembly (1).  We conclude that lptD4213 is a mutation that leads 
to an assembly defective substrate that accumulates on the Bam complex.   
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3.2.3.  LptD can be trapped by chemical crosslinking during folding on BamA as on-pathway 
folding intermediates 
We wondered if the crosslinked species that we observed represents an accumulated on-
pathway folding intermediate of LptD on BamA.  We have previously developed a S35-methionine 
pulse-chase method that allows us to observe seven intermediates along the biogenesis pathway of 
LptD (see Chapter Two) (1).  We wondered if we could extend and modify this method to allow 
crosslinking reaction during the process of folding to determine if the crosslinked species observed 
occurs at the Bam complex during β-barrel assembly.  We performed DSP crosslinking on [35S]-
methionine pulse-labeled Myc3-tagged LptD at different time points during the folding process 
and monitored the amount of crosslinked LptD on FLAG3-tagged BamA.  Both Myc3-tagged LptD 
and FLAG3-tagged BamA are functional and can fully complement their respective chromosomal 
copy.  We observed a band corresponding to wild type LptD at time points from 0 to 10 min, which 
subsequently disappeared by 20 min (Fig. 3.3A).  The time-dependent crosslinking observed is 
consistent with the fact that wild type LptD does not crosslink to BamA at steady state (Fig. 3.1, 
3.2).  Presumably the folding reaction occurred rapidly enough that wild type LptD does not 
accumulate on BamA to a significant level at steady state.   
When the mutant LptD, LptD4213, was subject to the same crosslinking during pulse-chase 
analysis, we observed that the amount of LptD4213 that crosslinked to BamA did not change over 
time (Fig. 3.3B).  Moreover, it appeared that a much larger percentage of the mutant substrate was 
crosslinked to BamA that that of the wild type substrate.   
We wondered if the mutant substrate that appears to be stably associated with BamA 
implies that the mutant is jammed on the Bam machine.  There is a single point mutant of 
LptD4213 at N274I that suppresses the phenotypes associated with the defective substrate.  We 
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examined this mutant, LptD61, in a similar pulse-chase crosslinking experiment.  We found that 
the LptD61 mutant showed time-dependent crosslinking to BamA that was similar to wild type 
(Fig. 3.3C).  Given that the only chemical difference between LptD4213 and LptD61 is a single 
amino acid substitution, we conclude that LptD4213 represents an on-pathway folding 
intermediate on the Bam complex.   
 
 
Figure 3.3.  LptD can be trapped by chemical crosslinking during folding on BamA.  (A-C) Cells 
expressing 3x-FLAG-BamA and LptD(wt/4213/61)-3x-Myc were pulsed with [35S]-methionine 
and chased with cold methionine.  The samples were washed, crosslinked with DSP, 
immunoprecipitated with α-FLAG antibody, and analyzed by SDS-PAGE / autoradiography.  A 
second immunoprecipitation with α-Myc antibody enriched BamA-LptD complex.   
 
3.2.4.  Loading of LptD to BamA is independent of LptE 
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We next wondered if defects in the Bam machine would slow the folding of wild type LptD 
substrates to allow trapping during folding.  We have shown that LptE is present at the Bam 
complex during the folding of LptD (Fig. 3.1 and 3.2).  A very challenging part of LptD/E 
assembly is that both polypeptide chains are delivered to the OM via different pathways and yet 
are seemingly assembled simultaneously at the Bam complex.  There are a couple of hypotheses 
on how LptD and LptE reach the Bam complex.  One hypothesis is that LptD and LptE go to the 
Bam complex independent of each other. A second hypothesis is that they form a pre-complex in 
the periplasm prior to folding.  This complex is then delivered to the Bam complex. A third 
hypothesis is that LptE is required for LptD to be loaded to Bam. Lastly, a fourth hypothesis is the 
opposite of the third, meaning that LptD is required for LptE to be recruited to Bam.   
In order to test the above hypotheses, we used a strain that conditionally expresses very 
low levels of LptE and tested whether we could trap stalled wild type LptD on BamA.  When LptE 
became the limiting reagent (Fig. 3.4, left panel), we saw significant accumulation of wild type 
LptD on BamA, comparable to the amount of LptD in lptD4213 mutant that was trapped during 
folding (Fig. 3.4, right panel).  The accumulated LptD on BamA can be subsequently rescued when 
LptE was no longer limiting, restoring the system back to a state that is similar to wild type (Fig. 
3.4, right panel).  This shows that wild type LptD can interact with BamA independent of LptE.  
However, earlier recruited LptD substrate was folded by the Bam complex only when LptE was 
sufficiently provided.  
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Figure 3.4.  Loading of LptD to BamA is independent of LptE.  α-LptD and α-LptE immunoblot 
analysis of OM fragments obtained from wt, lptD4213 and LptE-limiting strains expressing his-
BamA.  Both early log (OD = 0.22) and mid log (OD = 0.66) phase cells for the LptE-limiting 
strain are analyzed.  The same strains were crosslinked with DSP, affinity purified with Ni-NTA 
column and analyzed by α-LptD and α-LptE immunoblot under reducing conditions.   
 
3.2.5.  LptE mediates the interaction between LptD and BamD 
There are two essential Bam proteins that function to fold β-barrel proteins, BamA and 
BamD.  Defective LptD substrate, LptD4213, could be accumulated on BamD with LptE present 
(Fig. 3.5, lane 2).  However, when LptE is limiting, we did not observe wild type LptD crosslinked 
to BamD (Fig. 3.5, lane 3).  This suggests that, unlike the interaction between LptD and BamA, 
LptD cannot interact with BamD without LptE.  These experiments suggests that LptE is also 
present as part of a Bam complex that is required to fold wild type LptD.  Specifically, these results 
imply that LptE modulates the binding of BamD and LptD.   
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Figure. 3.5.  LptE mediates the interaction between LptD and BamD.  wt, lptD4213 and LptE-limiting 
strains with different LptE levels expressing BamD-his were crosslinked with DSP, affinity purified with 
Ni-NTA column and analyzed by α-LptD and α-LptE immunoblot under reducing conditions.  
 
3.2.6.  LptE and BamA form a stable complex in vitro 
As we mentioned before, LptE arrives at the OM through a separate Lol pathway, which 
sorts lipoproteins to their destinations by chaperoning their lipid anchor (9). Interestingly, the lipid 
anchor of LptE is not required for cell viability (10).  These results seem to suggest that there may 
be an independent pathway for LptE to reach the Bam complex for LptD folding.   
One implication of the preceding experiments is that LptE is present on the Bam complex 
only when LptD is there.  We wonder if LptE also forms a complex with BamA without LptD.   
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To test this hypothesis, Dr. Joseph Wzorek performed Ni-NTA affinity purification with 
his-tagged BamCDE and LptE, and monitored how much FLAG-tagged BamA can be co-purified 
(Fig. 3.6).  To our surprise, LptE pulled down BamA to a similar extent comparable to BamCDE 
(Fig. 3.6, compare lane 4 with 5), indicating that BamA can co-purify with LptE.  Furthermore, 
when purified BamA and his-tagged LptE were mixed together in vitro, they form a stable complex 
that could be purified by Fast Protein Liquid Chromatography (FPLC), suggesting that this 
interaction is quite stable (Fig. 3.7).   
 
by Dr. Wzorek 
Figure 3.6.  BamA co-purifies with LptE in vitro.   Ni-NTA affinity purification of BamCDE-his 
and LptE-his with FLAG-tagged BamA, visualized by SDS-PAGE followed by Coomassie Blue 
stain.  
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by Dr. Wzorek 
Figure 3.7.  BamA-LptE forms a stable complex in vitro.  FPLC purification of BamA/LptE-his 
complex formed by mixing purified components, visualized by SDS-PAGE followed by 
Coomassie Blue stain.  
 
3.2.7.  LptE modulates the activity of BamA in vitro 
We wondered if the BamA-LptE complex is capable of folding β-barrel substrates.  To test 
the activity of the Bam-LptE complex in vitro, we took advantage of a proteoliposome-based β-
barrel protein folding assay that we have developed (11-13).  We made proteopliposomes that 
contained either BamA or a BamA-LptE complex, and monitored their activity in folding FLAG-
tagged, urea denatured BamA substrate.  Proteoliposomes containing BamA alone showed 
moderate activity in folding FLAG-BamA, judging by the appearance of some folded FLAG-
BamA at 2 hours and that the amount of folded protein increased to 15% over a course of 4 hours 
(Fig. 3.8, left panel).  However, the proteoliposomes that contained the BamA-LptE complex 
showed much higher activity on FLAG-BamA substrate compared to proteoliposomes that 
contained BamA alone (Fig. 3.8, right panel).  25% of FLAG-BamA is folded by BamA-LptE 
complex at the end of a 4-hour period, while only 15% is folded by BamA alone.  Moreover, 
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significantly more FLAG-BamA (12% vs. 2%) is folded after 2 hours by BamA-LptE than BamA 
itself (Fig. 3.8, plotted chart), suggesting that BamA-LptE is better at initiating folding compared 
to BamA alone.  This result implies that LptE is able to form an active Bam complex with BamA 
without LptD in vitro.   
 
by Dr. Wzorek 
Figure 3.8.  LptE-BamA forms an active complex in vitro.  Urea denatured FLAG-BamA was 
incubated with proteoliposomes containing BamA or BamA/LptE-his.  Samples were processed 
using non-denaturing conditions and analyzed by seminative SDS-PAGE that preserve the β-barrel 
fold.  α-FLAG immunoblot analyses of the samples at different time points during the folding 
reaction.  Bands were quantified by densitometry and plotted against reaction time.   
 
3.2.8.  A model for LptD folding on Bam complex 
Based on the preceding results, we propose a model for LptD folding by the Bam complex 
(Fig. 3.9).  LptD is delivered to BamA by the periplasmic chaperone SurA (Fig. 3.10), which 
interacts with the P1 domain of BamA that resides in the periplasm (14, 15).  LptD could be 
delivered to an LptD-compatible Bam complex that already contains LptE, or an LptD-non-
compatible Bam complex that requires an LptE that arrives later to fold LptD.  We are not sure 
which pathway is preferred in the wild-type cells.  Once all four essential OM proteins are together, 
LptD transitions into a folding intermediate which further progresses to yield a folded LptD/E 
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complex with intermediary disulfide bonds.  Disulfide rearrangement finally produces a functional 
LPS translocon.   
 
Figure 3.9.  A model for LptD folding by Bam complex.  Two independent pathways that lead to 
the formation of a folding intermediate are shown.   
 
Figure 3.10.  SurA is required to fold LptD.  [35S]-Met pulse-chase of newly-synthesized LptD-
FLAG3 in wild type (see Chapter Two) and a ΔsurA background.   
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3.3.  Conclusion and Future Work 
We and others have shown that LptE is required to form the functional, properly oxidized 
LPS translocon (6-9, 10).  In this chapter, we characterize Bam assisted folding of LptD in the 
context of LptE.  We have identified LptE as a part of a Bam complex that is required to fold LptD.  
A folding intermediate on the Bam complex containing all four essential OM proteins, LptD/E and 
BamA/D, is identified.  LptD can be loaded to BamA independent of LptE, forming a folding 
competent pre-complex.  However, LptD does not interact with BamD without LptE, suggesting 
that folding does not occur before an LptD-compatible Bam complex is ready.  We have also 
shown that LptE and BamA form an active complex that is capable of folding β-barrels in vitro.   
As mentioned in Chapter Two, Bam assisted folding of general β-barrels is rapid (4).  In E. 
coli, there are millions of copies of β-barrel proteins in each cell and the Bam complex needs to 
fold all of them in a very limited time.  A typical β-barrel protein takes very little time (<30s) (4) 
to fold, however, it takes ¼ of a cell cycle to fold the LPS translocon (1).  This imposes a huge 
challenge for the Bam complex as one substrate that consists of less than 0.1% of the substrate 
pool is taking 25% of the cell’s capacity to fold β-barrel proteins.  Making a different kind of Bam 
complex that contains LptE be required to fold LptD may provide a capacity control mechanism 
at the OM.   
We have demonstrated that LptE can complex with BamA in the absence of LptD in vitro.  
We are trying to see if this interaction is relevant in the cell as well.  Also, we have no evidence 
that LptE is part of a Bam complex when folding β-barrel proteins other than LptD in vivo.   
Our long term goal is to elucidate a mechanism of β-barrel folding on the Bam complex.  
Over the past few years, X-ray crystal structures of all the individual Bam components have been 
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solved (16-18), but how the Bam complex handles substrates is still unclear.  Structural 
information of the Bam complex with or without LptE could be valuable in understanding how the 
multi-protein complex functions.  Substrates with photo-activatable amino acids that crosslink to 
different components of the Bam complex could provide information on site-specific interfaces 
that are important in substrate-Bam interactions.  
 
3.4.  Materials and Methods 
3.4.1.  Bacterial strains and growth conditions 
The wild-type strain used is MC4100 [F- araD139 Δ(argF-lac) U169 rpsL150 relA1 
flbB5301 ptsF25 deoC1 ptsF25  thi].  The lptDΔ330-352 (lptD4213) mutant strain used is NR698 
(20).  The lptDΔ330-352, N274I (lptD61) mutant strain used is NR731 (20). The LptE-depletion strain 
used that makes varying levels of LptE according to growth phase is MC4100 ara+ lptE- λatt(PBAD-
lptE).  It is constructed by removing the kanamycin resistance cassette on AM689 using methods 
previously described (28).  The surA- strain used is NR1215.  Luria-Bertani (LB) broth and 
M63/glucose minimal broth and agar were prepared as described previously (27).  Arabinose (0.2% 
w/v) was added for the growth of MC4100 ara+ lptE- λatt(PBAD-lptE).  Growth of strains was carried 
out at 37 oC unless explicitly indicated.  When appropriate, kanamycin (50 μg/ml) and 
spectinomycin (50 μg/ml) were added.  Amino acids were added at 50 μg/ml when indicated. 
 
3.4.2.  Plasmid construction 
To construct pET9aHis-BamA, a cassette containing the coding sequence of the His-BamA 
was inserted into pET9a.  Briefly, pET23/42His-BamA template was amplified by PCR (using 
primers 5’- AAT TGG ATC CAT GGC GAT GAA AAA GTT GCT C -3’ and 5’- ATA TGC TCA 
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GCT TAC CAG GTT TTA CCG ATG TTA AAC -3’) and the resulting PCR product was digested 
with BamHI and BlpI for > 3 h at 37 oC.  The digested PCR product was ligated to a pET9a vector 
that had been digested with BamHI and BlpI for > 3 h at 37 oC.  NovaBlue (Novagen) cells were 
transformed with 1 μl of the ligation product and plated onto LB plates containing 50 μg/ml 
kanamycin.  For each construct, plasmids from six colonies were isolated and sequenced. 
To construct pET9aBamD-His, a cassette containing the coding sequence of the BamD-
His was inserted into pET9a.  Briefly, pET23/42BamD-His was digested with digested with XbaI 
and BlpI for > 3 h at 37 oC.  The digested product was gel purified and the coding sequence of the 
BamD-His was ligated to a pET9a vector that had been digested with XbaI and BlpI for > 3 h at 
37 oC.  NovaBlue (Novagen) cells were transformed with 1 μl of the ligation product and plated 
onto LB plates containing 50 μg/ml kanamycin.  For each construct, plasmids from six colonies 
were isolated and sequenced. 
 To construct pET9aFLAG3-BamA, a cassette containing the coding sequence of the FLAG3 
tag was inserted into pET9aHis-BamA to replace the original His6 tag.  Briefly, the entire 
pET9aHis-BamA template was amplified by PCR (using primers 5’- A GAT CAT GAT ATC GAC 
TAT AAA GAC GAT GAT GAC AAA GAA GGG TTC GTA GTG AAA GAT-3’ and 5’- TCG ATA 
TCA TGA TCT TTG TAG TCG CCG TCG TGA TCT TTA TAA TCA GCA CCG TAT ACG GTG-3’) 
and the resulting PCR product mixture digested with DpnI for > 1 h at 37 oC.  NovaBlue (Novagen) 
cells were transformed with 1 μl of digested PCR product and plated onto LB plates containing 50 
μg/ml kanamycin.  For each construct, plasmids from six colonies were isolated and sequenced. 
 
3.4.3.  In vivo DSP crosslinking 
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Crosslinking experiments are based on techniques described by Thanabalu et al. (1998) 
with modifications. Stains MC4100, NR698, NR731, MC4100 ara+ lptE- λatt(PBAD-lptE) 
containing either pET9aHis-BamA or pET9aBamD-His were used in in vivo DSP crosslinking 
experiments.  Cells were grown in 500 mL of LB to OD600 ~0.6 unless explicitly indicated.  Cells 
were pelleted by centrifugation at 5000 x g for 15 min and the cell pellets were washed twice with 
25 ml of 150 mM of NaCl and 10 mM of NaH2PO4, pH = 7.2, and resuspended in the same buffer.  
DSP dissolved in DMSO was added to the cell suspension at a final concentration of 200 μg/mL 
and the cells were incubated for 30 min at 37oC.  The crosslinking reaction was quenched by 
addition 1 M Tris.HCl (pH = 8.0) to a final concentration of 20 mM, and cells were harvested by 
centrifugation at 5000 x g for 10 min.  Cell pellets were resuspended in 5 mL of 20 mM Tris.HCl 
(pH = 8.0), 150 mM NaCl, and 1% Anzergent 3-14 containing lysozyme (50 μg/mL), DNase I (50 
μg/mL), and RNase I (50 μg/mL), and were lysed by sonication.  In order to remove cell debris 
after lysis, the mixture was then centrifuged at 10,000 x g for 10 min.  The cleared lysate was 
supplemented with 20 mM Imidazole (pH = 8.0), and incubated with 200 μL of pre-equilibrated 
Ni-NTA resin for 30 min at 4 oC.  The column was then washed 4 times with 10 mL of 20 mM 
Tris.HCl (pH = 8.0), 300 mM NaCl, 40 mM Imidazole, 0.1% Triton X-100, and 0.1% SDS.  The 
column was eluted with 4 mL of 20 mM Tris.HCl (pH = 8.0), 300 mM NaCl, and 200 mM 
Imidazole.  The eluate was concentrated via ultrafiltration at 5000 x g for 20 min. The concentrated 
sample was used for SDS-PAGE and Western blot analysis.  
 
3.4.4.  In vivo DSP crosslinking of [35S]-pulse-labeled cells 
Stains MC4100 containing pET9aFLAG3-BamA and pLptD/LptD4213/LptD61-Myc3 were 
used in in vivo DSP crosslinking of [35S]-pulse-labeled cells.  A 25 mL culture was grown to OD600 
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~0.6 in M63/glucose minimal media supplemented with eighteen amino acids (minus methionine 
and cysteine) at 37 oC.  The culture was pulse-labeled with [35S]-methionine (200 μCi/ml final 
concentration) (American Radiochemicals) for 2 min and then chased with cold methionine (5 mM) 
at 37 oC.  At the indicated time points during the chase, a 5 mL culture aliquot was pelleted by 
centrifuging at 14,000 x g for 1 min.  The cell pellet was resuspended in 300 μL of 150mM of 
NaCl and 10mM of NaH2PO4, pH = 7.2, pelleted again at 18,000 g for 30 seconds, and resuspended 
in 300 μL of the same buffer. 3 μL of DMSO containing 75 μg of DSP was added to the 
resuspended cells and incubate at 37 oC for 30 min.  The crosslinking reaction was quenched by 
addition 1 M Tris.HCl (pH = 8.0) to a final concentration of 20 mM followed by addition of 50 μl 
of trichloroacetic acid (TCA, 70% in water) and incubated on ice for 20 min. Precipitated proteins 
were pelleted at 18,000 x g for 10 min at 4 oC, washed with 1 mL of ice-cold acetone, and then 
solubilized in 150 μl of 100 mM Tris.HCl, pH = 8.0 containing 1% SDS.  The sample was 
sonicated for 30 s to aid solubilization.  Following that, 1.4 mL of ice-cold IP buffer (50 mM 
Tris.HCl, pH = 8.0 containing 150 mM NaCl, 2% Triton X-100, 1 mM EDTA) was added and the 
sample was centrifuged at 18,000 x g for 10 min at 4 oC.  1.4 mL of the supernatant was transferred 
to another 1.5-ml tube containing 25 μl of anti-FLAG® M2 magnetic beads (Sigma).  The beads 
were washed and pre-equilibrated with 3 x 1 ml IP buffer before use.  The mixture was incubated 
on a rotary shaker for 3~4 h at 4 oC, and the beads were washed with 4 x 1 mL of ice-cold high 
salt buffer (50 mM Tris.HCl, pH = 8.0 containing 1 M NaCl, 1% Triton X-100, 1 mM EDTA) and 
1 x 1mL ice-cold 10 mM Tris.HCl, pH = 8.0 using a magnetic separation rack (New Englands 
Biolabs).  160 μl 100 mM Tris.HCl, pH = 8.0 containing 1% SDS was then added to the beads and 
the mixture heated for 10 min at 100 oC to elute the bound proteins. 10 μl of the eluate was mixed 
with 2X SDS reducing sample buffer.  1.4 mL of ice-cold IP buffer (50 mM Tris.HCl, pH 8.0 
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containing 150 mM NaCl, 2% Triton X-100, 1 mM EDTA) was added to the remaining 150 μl of 
the eluate and the sample was centrifuged at 18,000 x g for 10 min at 4 oC.  1.4 mL of the 
supernatant was transferred to another 1.5-ml tube containing 120 μl of anti-Myc agarose beads 
(Sigma).  The beads were washed and pre-equilibrated with 3 x 1 ml IP buffer before use.  The 
mixture was incubated on a rotary shaker for 3~4 h at 4 oC, and the beads were washed with 4 x 1 
mL of ice-cold high salt buffer (50 mM Tris.HCl, pH = 8.0 containing 1 M NaCl, 1% Triton X-
100, 1 mM EDTA) and 1 x 1mL ice-cold 10 mM Tris.HCl, pH = 8.0.  80 μl 2X SDS non-reducing 
sample buffer was then added to the beads and the mixture heated for 10 min at 100 oC to elute the 
bound proteins.  15 μl of eluted sample was applied to SDS-PAGE directly.  4-20% Tris.HCl 
polyacrylamide gels were used (running conditions: 150 V for 90 min).  The gel was then dried 
and exposed to phosphor storage screens for autoradiography. 
 
3.4.5.  In vivo EGS crosslinking 
Stains MC4100, NR698 containing pET9aHis-BamA were used in in vivo EGS 
crosslinking experiments.  The protocol is largely similar to that of in vivo DSP crosslinking with 
modifications.  Cells were grown in 500mL of LB to OD600 ~0.6, pelleted by centrifugation at 
5000 x g for 15 min. The cell pellets were washed twice with 25 ml of 150 mM of NaCl and 10 
mM of NaH2PO4, pH = 7.2 and resuspended in the same buffer.  EGS dissolved in DMSO was 
added to the cell suspension at a final concentration of 200 μg/mL, and the cells were incubated 
for 30 min at 37oC.  The crosslinking reaction was quenched by addition 1 M Tris.HCl (pH = 7.4) 
to a final concentration of 20 mM, and cells were harvested by centrifugation at 5000 x g for 10 
min.  Cell pellets were resuspended in 5 mL of 20 mM Tris-HCl (pH = 8.0), 150 mM NaCl, and 
1% Anzergent 3-14 containing lysozyme (50 μg/mL), DNase I (50 μg/mL), and RNase I (50 
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μg/mL), and were lysed by sonication.  In order to remove cell debris after lysis, the mixture was 
then centrifuged at 10,000 x g for 10 min.  The cleared lysate was supplemented with 20 mM 
Imidazole (pH 8.0), and incubated with 200μL of pre-equilibrated Ni-NTA resin for 30 min at 4 
oC.  The column was then washed 4 times with 10 mL of 20 mM Tris buffer (pH = 8.0), with 300 
mM NaCl, 40 mM Imidazole, 0.1% Triton X-100, and 0.1% SDS.  The column was eluted with 4 
mL of 20 mM Tris.HCl (pH = 8.0), 300 mM NaCl, and 200 mM Imidazole.  The eluate was 
concentrated via ultrafiltration at 5000 x g for 20 min (~30 μl) and added to 470 μl of freshly made 
1 M hydroxylamine.HCl, pH = 8.5, 0.02% Anzergent 3-14 and incubate at 37 oC for 4 hours, 
followed by dialysis against 1 L of 20mM Tris.HCl, pH = 8.0, 150 mM NaCl, 0.02% Anzergent 
3-14 overnight.  The resulting solution was concentrated via ultrafiltration at 18,000 x g for 20 
min.  The concentrated sample was used for SDS-PAGE and Western blot analysis.  
 
3.4.6.  Isolation of OM for analysis of LptD oxidation states 
OM analysis is performed as previously described (1). 
 
3.4.7.  Growth of MC4100 ara+ lptE- λatt(PBAD-lptE) for OM analysis and DSP crosslinking 
10-ml cultures were grown overnight at 37 oC in LB broth containing 0.2% arabinose.  
Cultures were pelleted and washed twice in equal volume of LB broth.  Fresh LB cultures (1.5-l) 
either containing 0.2% arabinose were inoculated with the washed cells to an initial OD600 of ~0.01 
and were grown at 37 oC until OD600 reaches ~0.21 and ~0.63.  The amount of cells equivalent to 
that in a 500-ml culture of OD600 ~0.5 was pelleted by centrifugation at 5000 x g for 20 min and 
subjected to OM analysis or DSP crosslinking (see above). 
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3.4.8.  Expression and Isolation of Denatured BamA or FLAG-BamA 
BamA and FLAG-BamA were expressed as inclusion bodies in a BL21(DE3) strain 
harboring pCH103 or pCH128, respectively. A 15 mL overnight culture was diluted 1:100 with 
LB containing 50 μg/mL carbenicillin. The cultures were shaken at 37 °C until an OD600 of 0.6 
was reached. Protein expression was induced via addition of 150 μL of 1 M IPTG (100 μM final 
concentration) and the cultures were shaken for an additional four hours. The cells were harvested 
via centrifugation at 5250 x g for 12 minutes, resuspended in 25 mL TBS (pH 8), and lysed via 
cell disrupter. The lysate was centrifuged at 5000 x g for 10 minutes and the resulting supernatant 
was discarded. The pellet was resuspended in 25 mL TBS (pH 8) and centrifuged once more at 
5000 x g. The resulting white pellet was treated with 4 mL of 8 M urea and rocked at room 
temperature for one hour. The resulting mixture was transferred to an epi-tube and spun at 16000 
x g for 10 minutes. The supernatant containing urea denatured BamA or FLAG-BamA was 
transferred to a new epi-tube for storage.  
 
3.4.9.  Expression and Purification of LptE-His 
LptE-His was expressed in a BL21(DE3) strain harboring pLptE-His. Overnight cultures (8 x 15 
mL) were diluted 1:100 with LB containing 50 μg/mL streptomycin. The cultures were shaken at 
37 °C until an OD600 of 0.1 was reached. At this time, the temperature of the shaker was reduced 
to 30 °C and the cultures were shaken until an OD6oo of 0.6 was reached. Protein expression was 
induced via addition of 150 μL of 1 M IPTG (100 μM final concentration) and the cultures were 
shaken for an additional fourteen hours at 30 °C. The cells were harvested via centrifugation at 
5250 x g for 12 minutes, resuspended in 4 x 25 mL TBS (pH 8), and lysed via two passes through 
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the cell disrupter. The lysate was centrifuged at 5000 x g for 10 minutes and the resulting 
supernatant was spun at 100,000 x g for 30 minutes. The pellet was resuspended in 30 mL TBS 
(pH 8), 2% TX-100 and 300 μL of 10 mg/mL lysozyme was added. The suspension was rocked at 
4 °C for 1.5 hours, upon which time the mixture was centrifuged once more at 100,000 x g. The 
resulting supernatant was applied to a Ni-NTA column (2 x 4 mL slurry) and rocked for 30 minutes 
at 4 °C. The resin was washed 2 x 20 mL of 20 mM imidazole, TBS (pH 8), 0.05% DDM and the 
protein was eluted with 16 mL of 200 mM imidazole, TBS (pH 8), 0.05% DDM. The eluate was 
concentrated with a 30 kDa concentrator and further purified via size exclusion chromatography 
(0.03% DDM, TBS (pH 8), 1 mM TCEP).  
 
3.4.10.  Expression and Purification of BamCDE-His 
BamC, BamD, and BamE-His8 were co-expressed in a BL21(DE3) strain harboring both pSK46 
and pBamE-His. Overnight cultures (4 x 15 mL) were diluted 1:100 with LB containing 50 μg/mL 
streptomycin and 50 μg/mL carbenicillin. The cultures were shaken at 37 °C until an OD600 of 0.6 
was reached. Protein expression was induced via addition of 150 μL of 1 M IPTG (100 μM final 
concentration) and the cultures were shaken for an additional four hours at 37 °C. The cells were 
harvested via centrifugation at 5250 x g for 12 minutes, resuspended in 4 x 25 mL TBS (pH 8), 
and lysed via two passes through the cell disrupter. The lysate was centrifuged at 5000 x g for 10 
minutes and the resulting supernatant was spun at 100,000 x g for 30 minutes. The pellet was 
resuspended in 30 mL TBS (pH 8), 2% TX-100 and 300 μL of 10 mg/mL lysozyme was added. 
The suspension was rocked at 4 °C for 1.5 hours, upon which time the mixture was centrifuged 
once more at 100,000 x g. The resulting supernatant was applied to a Ni-NTA column (2 x 4 mL 
slurry) and rocked for 30 minutes at 4 °C. The resin was washed 2 x 20 mL of 20 mM imidazole, 
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TBS (pH 8), 0.05% DDM and the protein was eluted with 16 mL of 200 mM imidazole, TBS (pH 
8), 0.05% DDM. The eluate was concentrated with a 50 kDa concentrator and further purified via 
size exclusion chromatography (0.03% DDM, TBS (pH 8), 1 mM TCEP). 
 
3.4.11.  Folding and Purification of BamA 
Urea denatured BamA prepared at a concentration of 1.0 mM in 8 M urea (see above) was diluted 
10-fold into 20 mM Tris (pH 8), 0.25% DDM. This solution was rocked at room temperature for 
24 hours, upon which time the solution was concentrated in a 50 kDa cutoff concentrator. The 
resulting solution was purified via size exclusion chromatography using TBS (pH 8), 0.03% DDM, 
1 mM TCEP as buffer. Individual fractions containing primarily folded BamA were combined and 
re-subjected to size exclusion chromatography with the same buffer as above in order to remove 
any residual unfolded BamA.  
 
3.4.12.  Folded FLAG-BamA Affinity Purifications 
FLAG-BamA was prepared at a concentration of 1.0 mM in 8 M urea (see above) and diluted 10-
fold into 20 mM Tris (pH 8), 0.25% DDM.  This solution was rocked at room temperature for 24 
hours, upon which time the solution was concentrated in a 50 kDa cutoff concentrator. Next, 100 
μL of a 50 μM solution containing both folded FLAG-BamA substrate and 50 μM either BamCDE-
His or 50 μM LptE-His was prepared (both BamCDE-His and LptE-His were independently 
purified via size exclusion chromatography as described above). The protein mixtures were 
incubated at room temperature for 15 minutes, upon which time 10 μL was removed for an “input” 
sample and 85 μL was added to a Ni-NTA column (prepared by pre-equilibrating 200 μL Ni-NTA 
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slurry with 0.05% DDM, TBS (pH 8), 20 mM imidazole). The resin was washed with 2 x 1 mL 
0.05% DDM, TBS (pH 8), 20 mM imidazole and the residual protein complex was eluted with 
600 μL 0.05% DDM, TBS (pH 8), 200 mM imidazole. The protein present in the eluate was TCA 
precipitated and analyzed via SDS-PAGE on a 4-20% gradient gel at 200 V for 40 minutes. The 
proteins were then detected by staining with Coomassie blue. 
 
3.4.13.  Size-Exclusion Chromatography with BamA and LptE-His 
A 1 mL solution of 20 μM BamA and 40 μM LptE-His (both expressed and purified as described 
above) was prepared in 0.03% DDM, TBS (pH 8), 1 mM TCEP and concentrated to 250 μL in a 
50 kDa concentrator. This material was immediately purified via size exclusion chromatography 
in the same buffer, and the fractions were analyzed via SDS-PAGE. The fractions containing both 
BamA and LptE-His were combined and concentrated in a 50 kDa concentrator to 250 μL. This 
procedure was repeated twice more to yield the purified BamA/LptE-His complex used for the 
proteoliposome activity assay.  
 
3.4.14.  Preparation of Proteliposomes Containing BamA or BamA/LptE-His 
A 200 uL solution of 10 μM BamA or BamA/LptE-His in 0.03% DDM, TBS (pH 8), 1 mM TCEP 
was prepared in a 1.5 mL epi-tube and treated with 40 μL of freshly dissolved 20 mg/mL E. coli 
phospholipids. This mixture was incubated on ice for 5 minutes, upon which time the solutions 
were diluted with 8 mL TBS (pH 8) and incubated on ice for 30 additional minutes. The solutions 
were spun at 300,000 x g for 2 hours and the resulting supernatant was removed. The pellets were 
resuspended in 200 μL TBS and used directly in the folding assay. 
98 
 
3.4.15.  Folding of FLAG-BamA into Proteoliposomes 
Folding reactions were performed in 0.2 mL PCR tubes containing 13 μL TBS, 5 μL 
proteoliposome suspension, and 2 μL of 5 μM FLAG-BamA (denatured in 8 M urea). Reactions 
were performed in a reverse time course manner. Following incubation for the designated time 
period at room temperature, reactions were quenched with 2x SDS sample buffer (125 mM Tris 
(pH 6.8), 4% SDS, 30% glycerol, 0.005% bromophenol blue, and 5% β-mercaptoethanol) and 
immediately subjected to SDS-PAGE on a 4-20% gradient gel at 150 V for 80 minutes at 4 °C. 
The proteins were transferred from the gel to a PVDF membrane by semi-dry transfer at 25 V for 
10 minutes. The products of the reaction were detected by immunoblotting with FLAG-HRP 
antibodies (used at a dilution of 1:100,000).  
 
3.4.16.  Pulse-chase analysis 
Strains MC4100, NR1215 containing pET23/42lptD-FLAG3 were used in pulse-chase 
experiments.  Pulse-chase experiments were essentially carried out according to published 
protocols (21).  Briefly, a 5-ml culture was grown to OD600 ~0.5 in M63/glucose minimal media 
supplemented with eighteen amino acids (minus methionine and cysteine) at 37 oC.  The culture 
was pulse-labeled with [35S]-methionine (100 μCi/ml final concentration) (American 
Radiochemicals) for 2 min and then chased with cold methionine (5 mM) at 37 oC.  At the indicated 
time point during the chase, a 800 μl culture aliquot was transferred to a 1.5-ml tube containing 80 
μl of trichloroacetic acid (TCA, 70% in water), incubated on ice for 20 min.  Precipitated proteins 
were pelleted at 18,000 x g for 10 min at 4 oC, washed with 700 μl ice-cold acetone, and then 
solubilized in 80 μl 100 mM Tris.HCl, pH 8.0 containing 1% SDS and 20 mM N-ethylmaleimide 
(NEM, Sigma).  The sample was sonicated for 30 s to aid solubilization.  Following that, 800 μl 
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of ice-cold IP buffer (50 mM Tris.HCl, pH 8.0 containing 150 mM NaCl, 2% Triton X-100, 1 mM 
EDTA) was added and the sample was centrifuged at 18,000 x g for 10 min at 4 oC.  700 μl of the 
supernatant was transferred to another 1.5-ml tube containing 2.5 μl of anti-FLAG® M2 magnetic 
beads (Sigma).  The beads were washed and pre-equilibrated with 3 x 1 ml IP buffer before use.  
The mixture was incubated on a rotary shaker for 1 h at 4 oC, and the beads were washed with 3 x 
800 μl of ice-cold high salt buffer (50 mM Tris.HCl, pH 8.0 containing 1 M NaCl, 1% Triton X-
100, 1 mM EDTA) and 1 x 800 μl ice-cold 10 mM Tris.HCl, pH 8.0 using a magnetic separation 
rack (New Englands Biolabs).  60 μl 2X SDS non-reducing sample buffer was then added to the 
beads and the mixture heated for 10 min at 100 oC to elute the bound proteins.  15 μl of eluted 
sample was applied to SDS-PAGE directly.  For reduction of disulfide bonds, 0.5 μl β-
mercaptoethanol (β-ME, Sigma) was added to 20 μl eluted sample and heated for 5 min at 100 oC 
before loading.  4-20% Tris.HCl polyacrylamide gels were used (running conditions: 150 V for 
120 min).  The gel was then dried and exposed to phosphor storage screens for autoradiography. 
 
3.4.17.  Antibodies 
Monoclonal α-His conjugated to horseradish peroxidase was purchased from Qiagen.  
Monoclonal α-FLAG conjugated to horseradish peroxidase was purchased from Sigma.  α-LptD 
(21) and α-LptE (6) antiserum were already described.  LptD antibody used in DSP and EGS 
crosslinking experiments is courtesy of Dr. Shin-ichiro Narita.   
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